https://www.psychiatrist.com/jcp/recovery-from-anorexia-and-bulimia-at-year-follow-up/key-takeaways/2026-09-03T19:41:50+00:00 https://www.psychiatrist.com/jcp/recovery-from-anorexia-and-bulimia-at-year-follow-up/how-to-decide-on-active-treatment-in-long-duration-eating-disorders/2026-09-03T19:41:49+00:00 https://www.psychiatrist.com/jcp/recovery-from-anorexia-and-bulimia-at-year-follow-up/how-to-use-early-recovery-to-estimate-anorexia-prognosis/2026-09-03T19:41:49+00:00 https://www.psychiatrist.com/jcp/recovery-from-anorexia-and-bulimia-at-year-follow-up/faq/2026-09-03T19:41:49+00:00 https://www.psychiatrist.com/jcp/recovery-from-anorexia-and-bulimia-at-year-follow-up/clinical-summary/2026-09-03T19:41:49+00:00 https://www.psychiatrist.com/jcp/procognitive-effects-of-therapeutic-agents-in-mdd/how-to-monitor-cognition-and-function-in-mdd-treatment/2026-09-03T19:41:40+00:00 https://www.psychiatrist.com/jcp/procognitive-effects-of-therapeutic-agents-in-mdd/how-to-choose-medication-for-cognitive-impairment-in-mdd/2026-09-03T19:41:40+00:00 https://www.psychiatrist.com/jcp/procognitive-effects-of-therapeutic-agents-in-mdd/faq/2026-09-03T19:41:40+00:00 https://www.psychiatrist.com/jcp/procognitive-effects-of-therapeutic-agents-in-mdd/clinical-summary/2026-09-03T19:41:40+00:00 https://www.psychiatrist.com/jcp/procognitive-effects-of-therapeutic-agents-in-mdd/key-takeaways/2026-09-03T19:41:40+00:00 https://www.psychiatrist.com/jcp/obstetric-risk-stimulant-nonstimulant-treatment-during-pregnancy/how-to-monitor-pregnancy-on-adhd-medication-treatment/2026-09-03T19:41:27+00:00 https://www.psychiatrist.com/jcp/obstetric-risk-stimulant-nonstimulant-treatment-during-pregnancy/how-to-counsel-adhd-medication-use-during-pregnancy/2026-09-03T19:41:27+00:00 https://www.psychiatrist.com/jcp/obstetric-risk-stimulant-nonstimulant-treatment-during-pregnancy/faq/2026-09-03T19:41:27+00:00 https://www.psychiatrist.com/jcp/obstetric-risk-stimulant-nonstimulant-treatment-during-pregnancy/clinical-summary/2026-09-03T19:41:27+00:00 https://www.psychiatrist.com/jcp/obstetric-risk-stimulant-nonstimulant-treatment-during-pregnancy/key-takeaways/2026-09-03T19:41:27+00:00 https://www.psychiatrist.com/jcp/safety-efficacy-aripiprazole-2-month-ready-to-use-960-mg/key-takeaways/2026-09-03T19:41:17+00:00 https://www.psychiatrist.com/jcp/safety-efficacy-aripiprazole-2-month-ready-to-use-960-mg/how-to-initiate-aripiprazole-two-month-injection-schizophrenia/2026-09-03T19:41:16+00:00 https://www.psychiatrist.com/jcp/safety-efficacy-aripiprazole-2-month-ready-to-use-960-mg/how-to-select-patients-for-aripiprazole-two-month-schizophrenia/2026-09-03T19:41:16+00:00 https://www.psychiatrist.com/jcp/safety-efficacy-aripiprazole-2-month-ready-to-use-960-mg/faq/2026-09-03T19:41:16+00:00 https://www.psychiatrist.com/jcp/safety-efficacy-aripiprazole-2-month-ready-to-use-960-mg/clinical-summary/2026-09-03T19:41:16+00:00 https://www.psychiatrist.com/pcc/recurrent-mental-health-presentations-public-hospital-services-focus-borderline-personality-disorder/how-to-use-bpd-length-of-stay-findings-discharge-planning/2026-09-03T19:40:58+00:00 https://www.psychiatrist.com/pcc/recurrent-mental-health-presentations-public-hospital-services-focus-borderline-personality-disorder/how-to-identify-high-risk-repeat-hospital-presentations-bpd/2026-09-03T19:40:58+00:00 https://www.psychiatrist.com/pcc/recurrent-mental-health-presentations-public-hospital-services-focus-borderline-personality-disorder/faq/2026-09-03T19:40:58+00:00 https://www.psychiatrist.com/pcc/recurrent-mental-health-presentations-public-hospital-services-focus-borderline-personality-disorder/clinical-summary/2026-09-03T19:40:58+00:00 https://www.psychiatrist.com/pcc/recurrent-mental-health-presentations-public-hospital-services-focus-borderline-personality-disorder/key-takeaways/2026-09-03T19:40:58+00:00 https://www.psychiatrist.com/jcp/importance-childhood-trauma-childhood-life-events/faq/2026-09-03T19:40:47+00:00 https://www.psychiatrist.com/jcp/importance-childhood-trauma-childhood-life-events/clinical-summary/2026-09-03T19:40:47+00:00 https://www.psychiatrist.com/jcp/importance-childhood-trauma-childhood-life-events/key-takeaways/2026-09-03T19:40:47+00:00 https://www.psychiatrist.com/jcp/importance-childhood-trauma-childhood-life-events/how-to-assess-childhood-trauma-in-adult-major-depression/2026-09-03T19:40:46+00:00 https://www.psychiatrist.com/pcc/contextualizing-relationship-between-social-isolation-substance-abuse/how-to-screen-socially-isolated-inpatients-for-substance-use/2026-09-03T19:38:33+00:00 https://www.psychiatrist.com/pcc/contextualizing-relationship-between-social-isolation-substance-abuse/faq/2026-09-03T19:38:33+00:00 https://www.psychiatrist.com/pcc/contextualizing-relationship-between-social-isolation-substance-abuse/clinical-summary/2026-09-03T19:38:33+00:00 https://www.psychiatrist.com/pcc/contextualizing-relationship-between-social-isolation-substance-abuse/key-takeaways/2026-09-03T19:38:33+00:00 https://www.psychiatrist.com/pcc/generative-artificial-intelligence-mental-health-primary-care-providers/how-to-use-nlp-in-suicide-risk-assessment/2026-08-28T22:26:44+00:00 https://www.psychiatrist.com/pcc/generative-artificial-intelligence-mental-health-primary-care-providers/how-to-counsel-patients-about-mental-health-chatbots/2026-08-28T22:26:44+00:00 https://www.psychiatrist.com/pcc/generative-artificial-intelligence-mental-health-primary-care-providers/faq/2026-08-28T22:26:44+00:00 https://www.psychiatrist.com/pcc/generative-artificial-intelligence-mental-health-primary-care-providers/clinical-summary/2026-08-28T22:26:44+00:00 https://www.psychiatrist.com/pcc/generative-artificial-intelligence-mental-health-primary-care-providers/key-takeaways/2026-08-28T22:26:44+00:00 https://www.psychiatrist.com/pcc/generative-artificial-intelligence-mental-health-primary-care-providers/how-to-establish-oversight-for-clinician-facing-ai-tools/2026-08-28T22:26:43+00:00 https://www.psychiatrist.com/pcc/effectiveness-tolerability-supratherapeutic-dosing-vortioxetine-patients-treatment-resistant-depression/key-takeaways/2026-08-21T15:03:13+00:00 https://www.psychiatrist.com/pcc/effectiveness-tolerability-supratherapeutic-dosing-vortioxetine-patients-treatment-resistant-depression/how-to-escalate-vortioxetine-in-treatment-resistant-depression/2026-08-21T15:03:12+00:00 https://www.psychiatrist.com/pcc/effectiveness-tolerability-supratherapeutic-dosing-vortioxetine-patients-treatment-resistant-depression/faq/2026-08-21T15:03:12+00:00 https://www.psychiatrist.com/pcc/effectiveness-tolerability-supratherapeutic-dosing-vortioxetine-patients-treatment-resistant-depression/clinical-summary/2026-08-21T15:03:12+00:00 https://www.psychiatrist.com/pcc/anxiety-depressive-symptoms-substance-use-schizophrenia/how-to-screen-early-phase-schizophrenia-for-comorbidities/2026-08-21T15:03:03+00:00 https://www.psychiatrist.com/pcc/anxiety-depressive-symptoms-substance-use-schizophrenia/faq/2026-08-21T15:03:03+00:00 https://www.psychiatrist.com/pcc/anxiety-depressive-symptoms-substance-use-schizophrenia/clinical-summary/2026-08-21T15:03:03+00:00 https://www.psychiatrist.com/pcc/anxiety-depressive-symptoms-substance-use-schizophrenia/key-takeaways/2026-08-21T15:03:03+00:00 https://www.psychiatrist.com/jcp/posttraumatic-stress-disorder-us-military-veterans-results-2019-2020-national-health-resilience-veterans-study/how-to-assess-ptsd-risk-in-trauma-exposed-veterans/2026-08-21T13:00:22+00:00 https://www.psychiatrist.com/jcp/posttraumatic-stress-disorder-us-military-veterans-results-2019-2020-national-health-resilience-veterans-study/faq/2026-08-21T13:00:22+00:00 https://www.psychiatrist.com/jcp/posttraumatic-stress-disorder-us-military-veterans-results-2019-2020-national-health-resilience-veterans-study/clinical-summary/2026-08-21T13:00:22+00:00 https://www.psychiatrist.com/jcp/posttraumatic-stress-disorder-us-military-veterans-results-2019-2020-national-health-resilience-veterans-study/key-takeaways/2026-08-21T13:00:22+00:00 https://www.psychiatrist.com/jcp/posttraumatic-stress-disorder-us-military-veterans-results-2019-2020-national-health-resilience-veterans-study/how-to-evaluate-functional-impairment-in-trauma-exposed-veterans/2026-08-21T13:00:21+00:00 https://www.psychiatrist.com/jcp/brexpiprazole-combined-sertraline-and-as-monotherapy-posttraumatic-stress-disorder-full-factorial-randomized-clinical-trial/how-to-monitor-brexpiprazole-sertraline-treatment-in-ptsd/2026-08-21T13:00:01+00:00 https://www.psychiatrist.com/jcp/brexpiprazole-combined-sertraline-and-as-monotherapy-posttraumatic-stress-disorder-full-factorial-randomized-clinical-trial/how-to-select-ptsd-patients-for-brexpiprazole-sertraline/2026-08-21T13:00:01+00:00 https://www.psychiatrist.com/jcp/brexpiprazole-combined-sertraline-and-as-monotherapy-posttraumatic-stress-disorder-full-factorial-randomized-clinical-trial/faq/2026-08-21T13:00:01+00:00 https://www.psychiatrist.com/jcp/brexpiprazole-combined-sertraline-and-as-monotherapy-posttraumatic-stress-disorder-full-factorial-randomized-clinical-trial/clinical-summary/2026-08-21T13:00:01+00:00 https://www.psychiatrist.com/jcp/brexpiprazole-combined-sertraline-and-as-monotherapy-posttraumatic-stress-disorder-full-factorial-randomized-clinical-trial/key-takeaways/2026-08-21T13:00:01+00:00 https://www.psychiatrist.com/jcp/lifes-essential-8-cardiovascular-health-suicide-mortality-south-korea/how-to-use-lifes-essential-8-for-suicide-risk-assessment/2026-08-21T12:59:53+00:00 https://www.psychiatrist.com/jcp/lifes-essential-8-cardiovascular-health-suicide-mortality-south-korea/faq/2026-08-21T12:59:53+00:00 https://www.psychiatrist.com/jcp/lifes-essential-8-cardiovascular-health-suicide-mortality-south-korea/clinical-summary/2026-08-21T12:59:53+00:00 https://www.psychiatrist.com/jcp/lifes-essential-8-cardiovascular-health-suicide-mortality-south-korea/key-takeaways/2026-08-21T12:59:53+00:00 https://www.psychiatrist.com/jcp/equine-assisted-therapy-posttraumatic-stress-disorder-military-veterans-open-trial/how-to-deliver-group-equine-assisted-therapy-for-ptsd/2026-08-21T12:59:46+00:00 https://www.psychiatrist.com/jcp/equine-assisted-therapy-posttraumatic-stress-disorder-military-veterans-open-trial/how-to-select-veterans-for-equine-assisted-ptsd-therapy/2026-08-21T12:59:46+00:00 https://www.psychiatrist.com/jcp/equine-assisted-therapy-posttraumatic-stress-disorder-military-veterans-open-trial/faq/2026-08-21T12:59:46+00:00 https://www.psychiatrist.com/jcp/equine-assisted-therapy-posttraumatic-stress-disorder-military-veterans-open-trial/clinical-summary/2026-08-21T12:59:46+00:00 https://www.psychiatrist.com/jcp/equine-assisted-therapy-posttraumatic-stress-disorder-military-veterans-open-trial/key-takeaways/2026-08-21T12:59:46+00:00 https://www.psychiatrist.com/jcp/intravenous-hydroxyzine-vs-haloperidol-delirium-retrospective-study/how-to-choose-intravenous-hydroxyzine-for-delirium/2026-08-21T12:59:39+00:00 https://www.psychiatrist.com/jcp/intravenous-hydroxyzine-vs-haloperidol-delirium-retrospective-study/how-to-screen-hospitalized-patients-for-delirium-risk/2026-08-21T12:59:39+00:00 https://www.psychiatrist.com/jcp/intravenous-hydroxyzine-vs-haloperidol-delirium-retrospective-study/faq/2026-08-21T12:59:39+00:00 https://www.psychiatrist.com/jcp/intravenous-hydroxyzine-vs-haloperidol-delirium-retrospective-study/clinical-summary/2026-08-21T12:59:39+00:00 https://www.psychiatrist.com/jcp/intravenous-hydroxyzine-vs-haloperidol-delirium-retrospective-study/key-takeaways/2026-08-21T12:59:39+00:00 https://www.psychiatrist.com/jcp/economic-burden-adults-major-depressive-disorder-united/how-to-assess-comorbidity-and-work-function-in-mdd/2026-08-21T12:59:28+00:00 https://www.psychiatrist.com/jcp/economic-burden-adults-major-depressive-disorder-united/faq/2026-08-21T12:59:28+00:00 https://www.psychiatrist.com/jcp/economic-burden-adults-major-depressive-disorder-united/clinical-summary/2026-08-21T12:59:28+00:00 https://www.psychiatrist.com/jcp/economic-burden-adults-major-depressive-disorder-united/key-takeaways/2026-08-21T12:59:28+00:00 https://www.psychiatrist.com/jcp/vortioxetine-versus-desvenlafaxine-patients-major-depressive-disorder-partial-response-ssri-therapy-results-vivre-study/how-to-switch-partial-ssri-responders-to-vortioxetine/2026-08-21T12:59:23+00:00 https://www.psychiatrist.com/jcp/vortioxetine-versus-desvenlafaxine-patients-major-depressive-disorder-partial-response-ssri-therapy-results-vivre-study/faq/2026-08-21T12:59:23+00:00 https://www.psychiatrist.com/jcp/vortioxetine-versus-desvenlafaxine-patients-major-depressive-disorder-partial-response-ssri-therapy-results-vivre-study/clinical-summary/2026-08-21T12:59:23+00:00 https://www.psychiatrist.com/jcp/vortioxetine-versus-desvenlafaxine-patients-major-depressive-disorder-partial-response-ssri-therapy-results-vivre-study/key-takeaways/2026-08-21T12:59:23+00:00 https://www.psychiatrist.com/jcp/vortioxetine-versus-desvenlafaxine-patients-major-depressive-disorder-partial-response-ssri-therapy-results-vivre-study/how-to-choose-a-switch-for-working-patients-with-mdd/2026-08-21T12:59:22+00:00 https://www.psychiatrist.com/jcp/zuranolone-vs-placebo-in-mdd/key-takeaways/2026-08-21T12:59:16+00:00 https://www.psychiatrist.com/jcp/zuranolone-vs-placebo-in-mdd/how-to-select-patients-for-zuranolone-mdd/2026-08-21T12:59:15+00:00 https://www.psychiatrist.com/jcp/zuranolone-vs-placebo-in-mdd/faq/2026-08-21T12:59:15+00:00 https://www.psychiatrist.com/jcp/zuranolone-vs-placebo-in-mdd/clinical-summary/2026-08-21T12:59:15+00:00 https://www.psychiatrist.com/jcp/risk-factors-for-reattempt-and-suicide-within-6-months-after-an-attempt-in-the-french-algos-cohort-a-survival-tree-analysis/clinical-summary/2026-08-21T12:58:50+00:00 https://www.psychiatrist.com/jcp/risk-factors-for-reattempt-and-suicide-within-6-months-after-an-attempt-in-the-french-algos-cohort-a-survival-tree-analysis/key-takeaways/2026-08-21T12:58:50+00:00 https://www.psychiatrist.com/jcp/risk-factors-for-reattempt-and-suicide-within-6-months-after-an-attempt-in-the-french-algos-cohort-a-survival-tree-analysis/how-to-stratify-six-month-reattempt-risk-after-suicide-attempt/2026-08-21T12:58:49+00:00 https://www.psychiatrist.com/jcp/risk-factors-for-reattempt-and-suicide-within-6-months-after-an-attempt-in-the-french-algos-cohort-a-survival-tree-analysis/faq/2026-08-21T12:58:49+00:00 https://www.psychiatrist.com/jcp/presenting-adhd-symptoms-subtypes-comorbid-disorders/how-to-screen-comorbidity-in-combined-adult-adhd/2026-08-17T19:14:50+00:00 https://www.psychiatrist.com/jcp/presenting-adhd-symptoms-subtypes-comorbid-disorders/how-to-assess-adult-adhd-inattentive-symptoms/2026-08-17T19:14:50+00:00 https://www.psychiatrist.com/jcp/presenting-adhd-symptoms-subtypes-comorbid-disorders/faq/2026-08-17T19:14:50+00:00 https://www.psychiatrist.com/jcp/presenting-adhd-symptoms-subtypes-comorbid-disorders/clinical-summary/2026-08-17T19:14:50+00:00 https://www.psychiatrist.com/jcp/presenting-adhd-symptoms-subtypes-comorbid-disorders/key-takeaways/2026-08-17T19:14:50+00:00 https://www.psychiatrist.com/pcc/vaccination-behavior-among-children-with-developmental-delay-their-siblings-cross-sectional-study-from-india/how-to-review-family-vaccination-in-developmental-delay/2026-08-17T19:14:40+00:00 https://www.psychiatrist.com/pcc/vaccination-behavior-among-children-with-developmental-delay-their-siblings-cross-sectional-study-from-india/faq/2026-08-17T19:14:40+00:00 https://www.psychiatrist.com/pcc/vaccination-behavior-among-children-with-developmental-delay-their-siblings-cross-sectional-study-from-india/clinical-summary/2026-08-17T19:14:40+00:00 https://www.psychiatrist.com/pcc/vaccination-behavior-among-children-with-developmental-delay-their-siblings-cross-sectional-study-from-india/key-takeaways/2026-08-17T19:14:40+00:00 https://www.psychiatrist.com/jcp/esketamine-nasal-spray-rapidly-reduces-depression/how-to-administer-esketamine-with-acute-suicide-risk-care/2026-08-17T19:14:34+00:00 https://www.psychiatrist.com/jcp/esketamine-nasal-spray-rapidly-reduces-depression/how-to-identify-candidates-for-esketamine-in-suicidal-mdd/2026-08-17T19:14:34+00:00 https://www.psychiatrist.com/jcp/esketamine-nasal-spray-rapidly-reduces-depression/faq/2026-08-17T19:14:34+00:00 https://www.psychiatrist.com/jcp/esketamine-nasal-spray-rapidly-reduces-depression/clinical-summary/2026-08-17T19:14:34+00:00 https://www.psychiatrist.com/jcp/esketamine-nasal-spray-rapidly-reduces-depression/key-takeaways/2026-08-17T19:14:34+00:00 https://www.psychiatrist.com/pcc/prevalence-bedtime-procrastination-university-students-examination-bedtime-procrastination-scale/how-to-identify-bedtime-procrastination-in-university-students/2026-08-17T19:14:24+00:00 https://www.psychiatrist.com/pcc/prevalence-bedtime-procrastination-university-students-examination-bedtime-procrastination-scale/faq/2026-08-17T19:14:24+00:00 https://www.psychiatrist.com/pcc/prevalence-bedtime-procrastination-university-students-examination-bedtime-procrastination-scale/clinical-summary/2026-08-17T19:14:24+00:00 https://www.psychiatrist.com/pcc/prevalence-bedtime-procrastination-university-students-examination-bedtime-procrastination-scale/key-takeaways/2026-08-17T19:14:24+00:00 https://www.psychiatrist.com/jcp/treating-insulin-resistance-metformin-strategy-improve-clinical-outcomes-treatment-resistant-bipolar-depression-trio-bd-study/how-to-use-metformin-in-insulin-resistant-trbd/2026-08-17T19:14:17+00:00 https://www.psychiatrist.com/jcp/treating-insulin-resistance-metformin-strategy-improve-clinical-outcomes-treatment-resistant-bipolar-depression-trio-bd-study/how-to-screen-trbd-for-insulin-resistance/2026-08-17T19:14:17+00:00 https://www.psychiatrist.com/jcp/treating-insulin-resistance-metformin-strategy-improve-clinical-outcomes-treatment-resistant-bipolar-depression-trio-bd-study/faq/2026-08-17T19:14:17+00:00 https://www.psychiatrist.com/jcp/treating-insulin-resistance-metformin-strategy-improve-clinical-outcomes-treatment-resistant-bipolar-depression-trio-bd-study/clinical-summary/2026-08-17T19:14:17+00:00 https://www.psychiatrist.com/jcp/treating-insulin-resistance-metformin-strategy-improve-clinical-outcomes-treatment-resistant-bipolar-depression-trio-bd-study/key-takeaways/2026-08-17T19:14:17+00:00 https://www.psychiatrist.com/jcp/high-frequency-transcranial-magnetic-stimulation-for-bipolar-depression/how-to-deliver-rtms-for-bipolar-depression/2026-08-17T19:14:09+00:00 https://www.psychiatrist.com/jcp/high-frequency-transcranial-magnetic-stimulation-for-bipolar-depression/faq/2026-08-17T19:14:09+00:00 https://www.psychiatrist.com/jcp/high-frequency-transcranial-magnetic-stimulation-for-bipolar-depression/clinical-summary/2026-08-17T19:14:09+00:00 https://www.psychiatrist.com/jcp/high-frequency-transcranial-magnetic-stimulation-for-bipolar-depression/key-takeaways/2026-08-17T19:14:09+00:00 https://www.psychiatrist.com/jcp/guanfacine-extended-release-improves-adhd-symptoms-in-japanese-adults/key-takeaways/2026-08-17T19:13:57+00:00 https://www.psychiatrist.com/jcp/guanfacine-extended-release-improves-adhd-symptoms-in-japanese-adults/how-to-initiate-and-monitor-guanfacine-in-adult-adhd/2026-08-17T19:13:56+00:00 https://www.psychiatrist.com/jcp/guanfacine-extended-release-improves-adhd-symptoms-in-japanese-adults/how-to-select-adults-with-adhd-for-guanfacine/2026-08-17T19:13:56+00:00 https://www.psychiatrist.com/jcp/guanfacine-extended-release-improves-adhd-symptoms-in-japanese-adults/faq/2026-08-17T19:13:56+00:00 https://www.psychiatrist.com/jcp/guanfacine-extended-release-improves-adhd-symptoms-in-japanese-adults/clinical-summary/2026-08-17T19:13:56+00:00 https://www.psychiatrist.com/jcp/auditory-hallucinations-in-dementia-with-lewy-bodies/how-to-evaluate-auditory-hallucination-risk-markers-in-dementia-with-lewy-bodies/2026-08-17T19:13:51+00:00 https://www.psychiatrist.com/jcp/auditory-hallucinations-in-dementia-with-lewy-bodies/how-to-assess-auditory-hallucinations-in-dementia-with-lewy-bodies/2026-08-17T19:13:51+00:00 https://www.psychiatrist.com/jcp/auditory-hallucinations-in-dementia-with-lewy-bodies/faq/2026-08-17T19:13:51+00:00 https://www.psychiatrist.com/jcp/auditory-hallucinations-in-dementia-with-lewy-bodies/clinical-summary/2026-08-17T19:13:51+00:00 https://www.psychiatrist.com/jcp/auditory-hallucinations-in-dementia-with-lewy-bodies/key-takeaways/2026-08-17T19:13:51+00:00 https://www.psychiatrist.com/jcp/long-term-follow-up-study-single-dose-psilocybin-treatment-resistant-episode-major-depressive-disorder/how-to-decide-when-to-add-treatment-after-psilocybin/2026-08-17T16:20:24+00:00 https://www.psychiatrist.com/jcp/long-term-follow-up-study-single-dose-psilocybin-treatment-resistant-episode-major-depressive-disorder/how-to-monitor-relapse-after-psilocybin-in-trd/2026-08-17T16:20:24+00:00 https://www.psychiatrist.com/jcp/long-term-follow-up-study-single-dose-psilocybin-treatment-resistant-episode-major-depressive-disorder/faq/2026-08-17T16:20:24+00:00 https://www.psychiatrist.com/jcp/long-term-follow-up-study-single-dose-psilocybin-treatment-resistant-episode-major-depressive-disorder/clinical-summary/2026-08-17T16:20:24+00:00 https://www.psychiatrist.com/jcp/long-term-follow-up-study-single-dose-psilocybin-treatment-resistant-episode-major-depressive-disorder/key-takeaways/2026-08-17T16:20:24+00:00 https://www.psychiatrist.com/pcc/sexual-abuse-impact-suicidal-ideation-attempts-psychiatric-illness-children-adolescents-with-posttraumatic-stress-disorder/how-to-assess-suicide-risk-in-youth-with-ptsd/2026-08-17T16:20:18+00:00 https://www.psychiatrist.com/pcc/sexual-abuse-impact-suicidal-ideation-attempts-psychiatric-illness-children-adolescents-with-posttraumatic-stress-disorder/faq/2026-08-17T16:20:18+00:00 https://www.psychiatrist.com/pcc/sexual-abuse-impact-suicidal-ideation-attempts-psychiatric-illness-children-adolescents-with-posttraumatic-stress-disorder/clinical-summary/2026-08-17T16:20:18+00:00 https://www.psychiatrist.com/pcc/sexual-abuse-impact-suicidal-ideation-attempts-psychiatric-illness-children-adolescents-with-posttraumatic-stress-disorder/key-takeaways/2026-08-17T16:20:18+00:00 https://www.psychiatrist.com/pcc/eye-tracking-game-for-training-attention-in-adhd/key-takeaways/2026-08-17T16:20:09+00:00 https://www.psychiatrist.com/pcc/eye-tracking-game-for-training-attention-in-adhd/faq/2026-08-17T16:20:08+00:00 https://www.psychiatrist.com/pcc/eye-tracking-game-for-training-attention-in-adhd/clinical-summary/2026-08-17T16:20:08+00:00 https://www.psychiatrist.com/jcp/peer-delivered-cognitive-behavioral-therapy-postpartum-depression-randomized-controlled-trial/how-to-implement-peer-delivered-group-cbt-for-postpartum-depression/2026-08-12T18:25:11+00:00 https://www.psychiatrist.com/jcp/peer-delivered-cognitive-behavioral-therapy-postpartum-depression-randomized-controlled-trial/how-to-identify-candidates-for-peer-cbt-postpartum-depression/2026-08-12T18:25:11+00:00 https://www.psychiatrist.com/jcp/peer-delivered-cognitive-behavioral-therapy-postpartum-depression-randomized-controlled-trial/faq/2026-08-12T18:25:11+00:00 https://www.psychiatrist.com/jcp/peer-delivered-cognitive-behavioral-therapy-postpartum-depression-randomized-controlled-trial/clinical-summary/2026-08-12T18:25:11+00:00 https://www.psychiatrist.com/jcp/peer-delivered-cognitive-behavioral-therapy-postpartum-depression-randomized-controlled-trial/key-takeaways/2026-08-12T18:25:11+00:00 https://www.psychiatrist.com/jcp/antidepressants-body-weight-comprehensive-review-meta/how-to-choose-antidepressants-when-body-weight-matters/2026-08-12T18:25:05+00:00 https://www.psychiatrist.com/jcp/antidepressants-body-weight-comprehensive-review-meta/faq/2026-08-12T18:25:05+00:00 https://www.psychiatrist.com/jcp/antidepressants-body-weight-comprehensive-review-meta/clinical-summary/2026-08-12T18:25:05+00:00 https://www.psychiatrist.com/jcp/antidepressants-body-weight-comprehensive-review-meta/key-takeaways/2026-08-12T18:25:05+00:00 https://www.psychiatrist.com/jcp/lithium-suicide-self-harm-chinese-adolescents-adults-bipolar-disorder/how-to-prioritize-lithium-for-suicide-risk-in-bipolar-disorder/2026-08-12T18:24:57+00:00 https://www.psychiatrist.com/jcp/lithium-suicide-self-harm-chinese-adolescents-adults-bipolar-disorder/faq/2026-08-12T18:24:57+00:00 https://www.psychiatrist.com/jcp/lithium-suicide-self-harm-chinese-adolescents-adults-bipolar-disorder/clinical-summary/2026-08-12T18:24:57+00:00 https://www.psychiatrist.com/jcp/lithium-suicide-self-harm-chinese-adolescents-adults-bipolar-disorder/key-takeaways/2026-08-12T18:24:57+00:00 https://www.psychiatrist.com/pcc/children-borderline-iq-parent-mediated-screen-time-usage-module/how-to-reduce-screen-time-in-children-with-borderline-iq/2026-08-12T18:24:49+00:00 https://www.psychiatrist.com/pcc/children-borderline-iq-parent-mediated-screen-time-usage-module/faq/2026-08-12T18:24:49+00:00 https://www.psychiatrist.com/pcc/children-borderline-iq-parent-mediated-screen-time-usage-module/clinical-summary/2026-08-12T18:24:49+00:00 https://www.psychiatrist.com/pcc/children-borderline-iq-parent-mediated-screen-time-usage-module/key-takeaways/2026-08-12T18:24:49+00:00 https://www.psychiatrist.com/jcp/exposure-based-video-therapy-obsessive-compulsive-disorder-posttraumatic-stress-disorder-adults/how-to-monitor-response-during-concurrent-erp-pe-treatment/2026-08-12T18:24:14+00:00 https://www.psychiatrist.com/jcp/exposure-based-video-therapy-obsessive-compulsive-disorder-posttraumatic-stress-disorder-adults/how-to-deliver-concurrent-erp-pe-for-ocd-ptsd/2026-08-12T18:24:14+00:00 https://www.psychiatrist.com/jcp/exposure-based-video-therapy-obsessive-compulsive-disorder-posttraumatic-stress-disorder-adults/faq/2026-08-12T18:24:14+00:00 https://www.psychiatrist.com/jcp/exposure-based-video-therapy-obsessive-compulsive-disorder-posttraumatic-stress-disorder-adults/clinical-summary/2026-08-12T18:24:14+00:00 https://www.psychiatrist.com/jcp/exposure-based-video-therapy-obsessive-compulsive-disorder-posttraumatic-stress-disorder-adults/key-takeaways/2026-08-12T18:24:14+00:00 https://www.psychiatrist.com/jcp/time-trends-maternal-adhd-medication-use-pregnancy/how-to-counsel-pregnant-patients-with-adhd-on-stimulants/2026-08-12T18:24:03+00:00 https://www.psychiatrist.com/jcp/time-trends-maternal-adhd-medication-use-pregnancy/faq/2026-08-12T18:24:03+00:00 https://www.psychiatrist.com/jcp/time-trends-maternal-adhd-medication-use-pregnancy/clinical-summary/2026-08-12T18:24:03+00:00 https://www.psychiatrist.com/jcp/time-trends-maternal-adhd-medication-use-pregnancy/key-takeaways/2026-08-12T18:24:03+00:00 https://www.psychiatrist.com/jcp/decades-after-the-nih-revitalization-actpersistent-gaps-in-diversity-of-us-antidepressant-trials/how-to-improve-diversity-in-antidepressant-trial-recruitment/2026-08-12T18:23:48+00:00 https://www.psychiatrist.com/jcp/decades-after-the-nih-revitalization-actpersistent-gaps-in-diversity-of-us-antidepressant-trials/how-to-assess-antidepressant-trial-generalizability-for-diverse-patients/2026-08-12T18:23:48+00:00 https://www.psychiatrist.com/jcp/decades-after-the-nih-revitalization-actpersistent-gaps-in-diversity-of-us-antidepressant-trials/faq/2026-08-12T18:23:48+00:00 https://www.psychiatrist.com/jcp/decades-after-the-nih-revitalization-actpersistent-gaps-in-diversity-of-us-antidepressant-trials/clinical-summary/2026-08-12T18:23:48+00:00 https://www.psychiatrist.com/jcp/decades-after-the-nih-revitalization-actpersistent-gaps-in-diversity-of-us-antidepressant-trials/key-takeaways/2026-08-12T18:23:48+00:00 https://www.psychiatrist.com/jcp/pharmacokinetics-viloxazine-er-breast-milk-healthy-lactating-women/key-takeaways/2026-08-12T18:23:39+00:00 https://www.psychiatrist.com/jcp/pharmacokinetics-viloxazine-er-breast-milk-healthy-lactating-women/how-to-counsel-breastfeeding-patients-on-viloxazine-er/2026-08-12T18:23:38+00:00 https://www.psychiatrist.com/jcp/pharmacokinetics-viloxazine-er-breast-milk-healthy-lactating-women/faq/2026-08-12T18:23:38+00:00 https://www.psychiatrist.com/jcp/pharmacokinetics-viloxazine-er-breast-milk-healthy-lactating-women/clinical-summary/2026-08-12T18:23:38+00:00 https://www.psychiatrist.com/pcc/health-care-providers-internet-gaming-disorder/key-takeaways/2026-08-12T18:23:23+00:00 https://www.psychiatrist.com/pcc/health-care-providers-internet-gaming-disorder/how-to-assess-possible-internet-gaming-disorder-in-clinical-care/2026-08-12T18:23:22+00:00 https://www.psychiatrist.com/pcc/health-care-providers-internet-gaming-disorder/faq/2026-08-12T18:23:22+00:00 https://www.psychiatrist.com/jcp/solriamfetol-attention-deficit-hyperactivity-disorder-in-adults-double-blind-placebo-controlled-pilot-study/key-takeaways/2026-08-12T18:23:08+00:00 https://www.psychiatrist.com/jcp/solriamfetol-attention-deficit-hyperactivity-disorder-in-adults-double-blind-placebo-controlled-pilot-study/how-to-titrate-and-monitor-solriamfetol-in-adult-adhd/2026-08-12T18:23:07+00:00 https://www.psychiatrist.com/jcp/solriamfetol-attention-deficit-hyperactivity-disorder-in-adults-double-blind-placebo-controlled-pilot-study/how-to-select-adults-with-adhd-for-solriamfetol/2026-08-12T18:23:07+00:00 https://www.psychiatrist.com/jcp/solriamfetol-attention-deficit-hyperactivity-disorder-in-adults-double-blind-placebo-controlled-pilot-study/faq/2026-08-12T18:23:07+00:00 https://www.psychiatrist.com/jcp/solriamfetol-attention-deficit-hyperactivity-disorder-in-adults-double-blind-placebo-controlled-pilot-study/clinical-summary/2026-08-12T18:23:07+00:00 https://www.psychiatrist.com/jcp/effect-of-lurasidone-on-anxiety-in-bipolar-depression/how-to-monitor-anxiety-response-during-lurasidone-treatment/2026-08-12T18:22:58+00:00 https://www.psychiatrist.com/jcp/effect-of-lurasidone-on-anxiety-in-bipolar-depression/how-to-assess-anxiety-and-sleep-before-lurasidone/2026-08-12T18:22:58+00:00 https://www.psychiatrist.com/jcp/effect-of-lurasidone-on-anxiety-in-bipolar-depression/faq/2026-08-12T18:22:58+00:00 https://www.psychiatrist.com/jcp/effect-of-lurasidone-on-anxiety-in-bipolar-depression/clinical-summary/2026-08-12T18:22:58+00:00 https://www.psychiatrist.com/jcp/effect-of-lurasidone-on-anxiety-in-bipolar-depression/key-takeaways/2026-08-12T18:22:58+00:00 https://www.psychiatrist.com/jcp/long-term-safety-of-esketamine-nasal-spray/key-takeaways/2026-08-12T18:22:47+00:00 https://www.psychiatrist.com/jcp/long-term-safety-of-esketamine-nasal-spray/how-to-monitor-long-term-esketamine-safety-in-trd/2026-08-12T18:22:46+00:00 https://www.psychiatrist.com/jcp/long-term-safety-of-esketamine-nasal-spray/how-to-adjust-esketamine-maintenance-dosing-in-trd/2026-08-12T18:22:46+00:00 https://www.psychiatrist.com/jcp/long-term-safety-of-esketamine-nasal-spray/faq/2026-08-12T18:22:46+00:00 https://www.psychiatrist.com/jcp/long-term-safety-of-esketamine-nasal-spray/clinical-summary/2026-08-12T18:22:46+00:00 https://www.psychiatrist.com/jcp/withania-somnifera-extract-for-schizophrenia-symptoms/faq/2026-08-12T16:08:36+00:00 https://www.psychiatrist.com/jcp/withania-somnifera-extract-for-schizophrenia-symptoms/clinical-summary/2026-08-12T16:08:36+00:00 https://www.psychiatrist.com/jcp/withania-somnifera-extract-for-schizophrenia-symptoms/key-takeaways/2026-08-12T16:08:36+00:00 https://www.psychiatrist.com/jcp/withania-somnifera-extract-for-schizophrenia-symptoms/how-to-use-adjunctive-ashwagandha-in-schizophrenia-exacerbation/2026-08-12T16:08:35+00:00 https://www.psychiatrist.com/jcp/clinical-outcomes-intravenous-ketamine-for-depression-va-health-system/clinical-summary/2026-08-12T16:08:31+00:00 https://www.psychiatrist.com/jcp/clinical-outcomes-intravenous-ketamine-for-depression-va-health-system/key-takeaways/2026-08-12T16:08:31+00:00 https://www.psychiatrist.com/jcp/clinical-outcomes-intravenous-ketamine-for-depression-va-health-system/how-to-structure-repeated-iv-ketamine-treatment-depression/2026-08-12T16:08:30+00:00 https://www.psychiatrist.com/jcp/clinical-outcomes-intravenous-ketamine-for-depression-va-health-system/how-to-select-va-patients-for-iv-ketamine/2026-08-12T16:08:30+00:00 https://www.psychiatrist.com/jcp/clinical-outcomes-intravenous-ketamine-for-depression-va-health-system/faq/2026-08-12T16:08:30+00:00 https://www.psychiatrist.com/jcp/hyperbaric-oxygen-therapy-controlled-trial-veterans-ptsd/how-to-deliver-hbot-for-combat-ptsd-veterans/2026-08-12T16:08:25+00:00 https://www.psychiatrist.com/jcp/hyperbaric-oxygen-therapy-controlled-trial-veterans-ptsd/how-to-select-veterans-for-hbot-in-ptsd/2026-08-12T16:08:25+00:00 https://www.psychiatrist.com/jcp/hyperbaric-oxygen-therapy-controlled-trial-veterans-ptsd/faq/2026-08-12T16:08:25+00:00 https://www.psychiatrist.com/jcp/hyperbaric-oxygen-therapy-controlled-trial-veterans-ptsd/clinical-summary/2026-08-12T16:08:25+00:00 https://www.psychiatrist.com/jcp/hyperbaric-oxygen-therapy-controlled-trial-veterans-ptsd/key-takeaways/2026-08-12T16:08:25+00:00 https://www.psychiatrist.com/jcp/preventive-effects-of-lamotrigine-in-bipolar-ii-versus-bipolar-i-disorder/how-to-start-lamotrigine-safely-in-bipolar-disorder/2026-08-12T16:08:19+00:00 https://www.psychiatrist.com/jcp/preventive-effects-of-lamotrigine-in-bipolar-ii-versus-bipolar-i-disorder/how-to-use-lamotrigine-maintenance-in-bipolar-ii/2026-08-12T16:08:19+00:00 https://www.psychiatrist.com/jcp/preventive-effects-of-lamotrigine-in-bipolar-ii-versus-bipolar-i-disorder/faq/2026-08-12T16:08:19+00:00 https://www.psychiatrist.com/jcp/preventive-effects-of-lamotrigine-in-bipolar-ii-versus-bipolar-i-disorder/clinical-summary/2026-08-12T16:08:19+00:00 https://www.psychiatrist.com/jcp/preventive-effects-of-lamotrigine-in-bipolar-ii-versus-bipolar-i-disorder/key-takeaways/2026-08-12T16:08:19+00:00 https://www.psychiatrist.com/jcp/efficacy-safety-iloperidone-in-bipolar-mania/how-to-monitor-iloperidone-safety-in-bipolar-mania/2026-08-12T16:08:07+00:00 https://www.psychiatrist.com/jcp/efficacy-safety-iloperidone-in-bipolar-mania/how-to-initiate-iloperidone-for-acute-bipolar-mania/2026-08-12T16:08:07+00:00 https://www.psychiatrist.com/jcp/efficacy-safety-iloperidone-in-bipolar-mania/faq/2026-08-12T16:08:07+00:00 https://www.psychiatrist.com/jcp/efficacy-safety-iloperidone-in-bipolar-mania/clinical-summary/2026-08-12T16:08:07+00:00 https://www.psychiatrist.com/jcp/efficacy-safety-iloperidone-in-bipolar-mania/key-takeaways/2026-08-12T16:08:07+00:00 https://www.psychiatrist.com/jcp/remote-trial-transcranial-alternating-current-stimulation-for-depression/key-takeaways/2026-07-22T19:47:12+00:00 https://www.psychiatrist.com/jcp/remote-trial-transcranial-alternating-current-stimulation-for-depression/how-to-select-and-initiate-home-tacs-for-mdd/2026-07-22T19:47:11+00:00 https://www.psychiatrist.com/jcp/remote-trial-transcranial-alternating-current-stimulation-for-depression/faq/2026-07-22T19:47:11+00:00 https://www.psychiatrist.com/jcp/remote-trial-transcranial-alternating-current-stimulation-for-depression/clinical-summary/2026-07-22T19:47:11+00:00 https://www.psychiatrist.com/jcp/decreased-alcohol-use-disorder-symptoms-with-semaglutide-for-weight-loss-a-case-series/clinical-summary/2026-07-22T19:47:05+00:00 https://www.psychiatrist.com/jcp/decreased-alcohol-use-disorder-symptoms-with-semaglutide-for-weight-loss-a-case-series/key-takeaways/2026-07-22T19:47:05+00:00 https://www.psychiatrist.com/jcp/decreased-alcohol-use-disorder-symptoms-with-semaglutide-for-weight-loss-a-case-series/how-to-monitor-audit-scores-during-semaglutide-weight-loss/2026-07-22T19:47:04+00:00 https://www.psychiatrist.com/jcp/decreased-alcohol-use-disorder-symptoms-with-semaglutide-for-weight-loss-a-case-series/faq/2026-07-22T19:47:04+00:00 https://www.psychiatrist.com/jcp/rct-of-heated-hatha-yoga-for-depression/key-takeaways/2026-07-22T19:47:00+00:00 https://www.psychiatrist.com/jcp/rct-of-heated-hatha-yoga-for-depression/how-to-select-patients-for-heated-yoga-depression/2026-07-22T19:46:59+00:00 https://www.psychiatrist.com/jcp/rct-of-heated-hatha-yoga-for-depression/faq/2026-07-22T19:46:59+00:00 https://www.psychiatrist.com/jcp/rct-of-heated-hatha-yoga-for-depression/clinical-summary/2026-07-22T19:46:59+00:00 https://www.psychiatrist.com/pcc/triggers-characteristics-brain-zaps-according-findings-internet-questionnaire/how-to-identify-brain-zaps-after-antidepressant-discontinuation/2026-07-22T19:46:53+00:00 https://www.psychiatrist.com/pcc/triggers-characteristics-brain-zaps-according-findings-internet-questionnaire/faq/2026-07-22T19:46:53+00:00 https://www.psychiatrist.com/pcc/triggers-characteristics-brain-zaps-according-findings-internet-questionnaire/clinical-summary/2026-07-22T19:46:53+00:00 https://www.psychiatrist.com/pcc/triggers-characteristics-brain-zaps-according-findings-internet-questionnaire/key-takeaways/2026-07-22T19:46:53+00:00 https://www.psychiatrist.com/pcc/triggers-characteristics-brain-zaps-according-findings-internet-questionnaire/how-to-manage-brain-zaps-during-antidepressant-withdrawal/2026-07-22T19:46:52+00:00 https://www.psychiatrist.com/pcc/association-between-problematic-social-media-use-attention-deficit-hyperactivity-disorder-sample-lebanese-adults/how-to-screen-adults-with-attention-problems-for-social-media-use/2026-07-22T19:45:53+00:00 https://www.psychiatrist.com/pcc/association-between-problematic-social-media-use-attention-deficit-hyperactivity-disorder-sample-lebanese-adults/faq/2026-07-22T19:45:53+00:00 https://www.psychiatrist.com/pcc/association-between-problematic-social-media-use-attention-deficit-hyperactivity-disorder-sample-lebanese-adults/clinical-summary/2026-07-22T19:45:53+00:00 https://www.psychiatrist.com/pcc/association-between-problematic-social-media-use-attention-deficit-hyperactivity-disorder-sample-lebanese-adults/key-takeaways/2026-07-22T19:45:53+00:00 https://www.psychiatrist.com/jcp/brexpiprazole-functioning-schizophrenia-hostility-agitation-symptoms-post-hoc-analysis/key-takeaways/2026-07-22T00:57:27+00:00 https://www.psychiatrist.com/jcp/brexpiprazole-functioning-schizophrenia-hostility-agitation-symptoms-post-hoc-analysis/how-to-monitor-brexpiprazole-response-in-schizophrenia-with-hostility-agitation/2026-07-22T00:57:26+00:00 https://www.psychiatrist.com/jcp/brexpiprazole-functioning-schizophrenia-hostility-agitation-symptoms-post-hoc-analysis/how-to-identify-hostility-and-agitation-in-schizophrenia/2026-07-22T00:57:26+00:00 https://www.psychiatrist.com/jcp/brexpiprazole-functioning-schizophrenia-hostility-agitation-symptoms-post-hoc-analysis/faq/2026-07-22T00:57:26+00:00 https://www.psychiatrist.com/jcp/brexpiprazole-functioning-schizophrenia-hostility-agitation-symptoms-post-hoc-analysis/clinical-summary/2026-07-22T00:57:26+00:00 https://www.psychiatrist.com/jcp/risk-factors-suicide-attempts-hospitalization-brazilian-healthcare-professionals/how-to-triage-suicide-attempt-risk-in-distressed-health-care-workers/2026-07-22T00:57:20+00:00 https://www.psychiatrist.com/jcp/risk-factors-suicide-attempts-hospitalization-brazilian-healthcare-professionals/faq/2026-07-22T00:57:20+00:00 https://www.psychiatrist.com/jcp/risk-factors-suicide-attempts-hospitalization-brazilian-healthcare-professionals/clinical-summary/2026-07-22T00:57:20+00:00 https://www.psychiatrist.com/jcp/risk-factors-suicide-attempts-hospitalization-brazilian-healthcare-professionals/key-takeaways/2026-07-22T00:57:20+00:00 https://www.psychiatrist.com/jcp/risk-factors-suicide-attempts-hospitalization-brazilian-healthcare-professionals/how-to-triage-psychiatric-hospitalization-risk-in-distressed-health-care-workers/2026-07-22T00:57:19+00:00 https://www.psychiatrist.com/jcp/obstetric-outcomes-second-generation-oral-vs-long-acting-antipsychotics/how-to-choose-laia-vs-oral-antipsychotics-pregnancy/2026-07-22T00:56:29+00:00 https://www.psychiatrist.com/jcp/obstetric-outcomes-second-generation-oral-vs-long-acting-antipsychotics/faq/2026-07-22T00:56:29+00:00 https://www.psychiatrist.com/jcp/obstetric-outcomes-second-generation-oral-vs-long-acting-antipsychotics/clinical-summary/2026-07-22T00:56:29+00:00 https://www.psychiatrist.com/jcp/obstetric-outcomes-second-generation-oral-vs-long-acting-antipsychotics/key-takeaways/2026-07-22T00:56:29+00:00 https://www.psychiatrist.com/jcp/hiv-diagnosis-prep-prescription-commercially-insured-bipolar-disorder/how-to-identify-bipolar-disorder-patients-for-prep/2026-07-22T00:55:21+00:00 https://www.psychiatrist.com/jcp/hiv-diagnosis-prep-prescription-commercially-insured-bipolar-disorder/faq/2026-07-22T00:55:21+00:00 https://www.psychiatrist.com/jcp/hiv-diagnosis-prep-prescription-commercially-insured-bipolar-disorder/clinical-summary/2026-07-22T00:55:21+00:00 https://www.psychiatrist.com/jcp/hiv-diagnosis-prep-prescription-commercially-insured-bipolar-disorder/key-takeaways/2026-07-22T00:55:21+00:00 https://www.psychiatrist.com/jcp/hiv-diagnosis-prep-prescription-commercially-insured-bipolar-disorder/how-to-integrate-prep-into-psychiatric-care-bipolar-disorder/2026-07-22T00:55:20+00:00 https://www.psychiatrist.com/pcc/borderline-symptoms-list-23-brazilian-portuguese/how-to-monitor-borderline-symptoms-with-brazilian-bsl-23/2026-07-22T00:22:08+00:00 https://www.psychiatrist.com/pcc/borderline-symptoms-list-23-brazilian-portuguese/how-to-use-brazilian-bsl-23-in-borderline-assessment/2026-07-22T00:22:08+00:00 https://www.psychiatrist.com/pcc/borderline-symptoms-list-23-brazilian-portuguese/faq/2026-07-22T00:22:08+00:00 https://www.psychiatrist.com/pcc/borderline-symptoms-list-23-brazilian-portuguese/clinical-summary/2026-07-22T00:22:08+00:00 https://www.psychiatrist.com/pcc/borderline-symptoms-list-23-brazilian-portuguese/key-takeaways/2026-07-22T00:22:08+00:00 https://www.psychiatrist.com/jcp/identifying-thresholds-early-opioid-use-frequency-predicting-buprenorphine-outcomes/how-to-use-three-week-opioid-use-threshold-buprenorphine/2026-07-16T19:30:22+00:00 https://www.psychiatrist.com/jcp/identifying-thresholds-early-opioid-use-frequency-predicting-buprenorphine-outcomes/how-to-identify-early-buprenorphine-nonresponse-in-two-weeks/2026-07-16T19:30:22+00:00 https://www.psychiatrist.com/jcp/identifying-thresholds-early-opioid-use-frequency-predicting-buprenorphine-outcomes/faq/2026-07-16T19:30:22+00:00 https://www.psychiatrist.com/jcp/identifying-thresholds-early-opioid-use-frequency-predicting-buprenorphine-outcomes/clinical-summary/2026-07-16T19:30:22+00:00 https://www.psychiatrist.com/jcp/identifying-thresholds-early-opioid-use-frequency-predicting-buprenorphine-outcomes/key-takeaways/2026-07-16T19:30:22+00:00 https://www.psychiatrist.com/jcp/innovation-drug-development-analysis-fda-approved-psychiatric-drugs-2012-2024/how-to-evaluate-new-psychiatric-drug-innovation/2026-07-16T19:30:16+00:00 https://www.psychiatrist.com/jcp/innovation-drug-development-analysis-fda-approved-psychiatric-drugs-2012-2024/faq/2026-07-16T19:30:16+00:00 https://www.psychiatrist.com/jcp/innovation-drug-development-analysis-fda-approved-psychiatric-drugs-2012-2024/clinical-summary/2026-07-16T19:30:16+00:00 https://www.psychiatrist.com/jcp/innovation-drug-development-analysis-fda-approved-psychiatric-drugs-2012-2024/key-takeaways/2026-07-16T19:30:16+00:00 https://www.psychiatrist.com/jcp/digital-multi-domain-cognitive-intervention-high-risk-dementia-randomized-clinical-trial/how-to-implement-digital-multidomain-dementia-risk-reduction-in-older-adults/2026-07-16T19:30:12+00:00 https://www.psychiatrist.com/jcp/digital-multi-domain-cognitive-intervention-high-risk-dementia-randomized-clinical-trial/how-to-identify-high-risk-older-adults-for-digital-dementia-prevention/2026-07-16T19:30:12+00:00 https://www.psychiatrist.com/jcp/digital-multi-domain-cognitive-intervention-high-risk-dementia-randomized-clinical-trial/faq/2026-07-16T19:30:12+00:00 https://www.psychiatrist.com/jcp/digital-multi-domain-cognitive-intervention-high-risk-dementia-randomized-clinical-trial/clinical-summary/2026-07-16T19:30:12+00:00 https://www.psychiatrist.com/jcp/digital-multi-domain-cognitive-intervention-high-risk-dementia-randomized-clinical-trial/key-takeaways/2026-07-16T19:30:12+00:00 https://www.psychiatrist.com/pcc/health-care-provider-family-support-substance-use/clinical-summary/2026-07-16T19:30:07+00:00 https://www.psychiatrist.com/pcc/health-care-provider-family-support-substance-use/key-takeaways/2026-07-16T19:30:07+00:00 https://www.psychiatrist.com/pcc/health-care-provider-family-support-substance-use/how-to-refer-families-for-sud-support-services/2026-07-16T19:30:06+00:00 https://www.psychiatrist.com/pcc/health-care-provider-family-support-substance-use/faq/2026-07-16T19:30:06+00:00 https://www.psychiatrist.com/jcp/geographic-differences-cannabis-use-disorder-us-veteran-population/key-takeaways/2026-07-16T17:31:05+00:00 https://www.psychiatrist.com/jcp/geographic-differences-cannabis-use-disorder-us-veteran-population/how-to-screen-veterans-for-probable-cannabis-use-disorder/2026-07-16T17:31:04+00:00 https://www.psychiatrist.com/jcp/geographic-differences-cannabis-use-disorder-us-veteran-population/faq/2026-07-16T17:31:04+00:00 https://www.psychiatrist.com/jcp/geographic-differences-cannabis-use-disorder-us-veteran-population/clinical-summary/2026-07-16T17:31:04+00:00 https://www.psychiatrist.com/pcc/comorbid-cardiovascular-disease-ptsd-older-us-veterans/how-to-assess-clinical-burden-in-older-veterans-with-cvd-and-ptsd/2026-07-16T17:30:55+00:00 https://www.psychiatrist.com/pcc/comorbid-cardiovascular-disease-ptsd-older-us-veterans/how-to-screen-older-veterans-for-comorbid-cvd-and-ptsd/2026-07-16T17:30:55+00:00 https://www.psychiatrist.com/pcc/comorbid-cardiovascular-disease-ptsd-older-us-veterans/faq/2026-07-16T17:30:55+00:00 https://www.psychiatrist.com/pcc/comorbid-cardiovascular-disease-ptsd-older-us-veterans/clinical-summary/2026-07-16T17:30:55+00:00 https://www.psychiatrist.com/pcc/comorbid-cardiovascular-disease-ptsd-older-us-veterans/key-takeaways/2026-07-16T17:30:55+00:00 https://www.psychiatrist.com/jcp/glp-1-receptor-agonists-overdose-risk-veterans-type-2-diabetes-opioid-use-disorder/how-to-apply-glp-1-overdose-risk-data-in-veterans-with-t2dm-and-oud/2026-07-16T17:30:49+00:00 https://www.psychiatrist.com/jcp/glp-1-receptor-agonists-overdose-risk-veterans-type-2-diabetes-opioid-use-disorder/faq/2026-07-16T17:30:49+00:00 https://www.psychiatrist.com/jcp/glp-1-receptor-agonists-overdose-risk-veterans-type-2-diabetes-opioid-use-disorder/clinical-summary/2026-07-16T17:30:49+00:00 https://www.psychiatrist.com/jcp/glp-1-receptor-agonists-overdose-risk-veterans-type-2-diabetes-opioid-use-disorder/key-takeaways/2026-07-16T17:30:49+00:00 https://www.psychiatrist.com/jcp/factors-revisiting-emergency-department-suicidal-behavior-children-adolescents/how-to-risk-stratify-youth-after-ed-suicidal-behavior/2026-07-16T17:30:42+00:00 https://www.psychiatrist.com/jcp/factors-revisiting-emergency-department-suicidal-behavior-children-adolescents/faq/2026-07-16T17:30:42+00:00 https://www.psychiatrist.com/jcp/factors-revisiting-emergency-department-suicidal-behavior-children-adolescents/clinical-summary/2026-07-16T17:30:42+00:00 https://www.psychiatrist.com/jcp/factors-revisiting-emergency-department-suicidal-behavior-children-adolescents/key-takeaways/2026-07-16T17:30:42+00:00 https://www.psychiatrist.com/jcp/how-many-criteria-define-dsm-5-mixed-features-specifier-depressed-patients/how-to-interpret-two-mixed-features-in-depression/2026-07-16T17:30:23+00:00 https://www.psychiatrist.com/jcp/how-many-criteria-define-dsm-5-mixed-features-specifier-depressed-patients/how-to-assess-dsm-5-mixed-features-in-depressed-patients/2026-07-16T17:30:23+00:00 https://www.psychiatrist.com/jcp/how-many-criteria-define-dsm-5-mixed-features-specifier-depressed-patients/faq/2026-07-16T17:30:23+00:00 https://www.psychiatrist.com/jcp/how-many-criteria-define-dsm-5-mixed-features-specifier-depressed-patients/clinical-summary/2026-07-16T17:30:23+00:00 https://www.psychiatrist.com/jcp/how-many-criteria-define-dsm-5-mixed-features-specifier-depressed-patients/key-takeaways/2026-07-16T17:30:23+00:00 https://www.psychiatrist.com/jcp/video-therapy-habit-reversal-training-body-focused-repetitive-behaviors/how-to-monitor-response-to-video-hrt-for-bfrbs/2026-07-16T17:30:16+00:00 https://www.psychiatrist.com/jcp/video-therapy-habit-reversal-training-body-focused-repetitive-behaviors/how-to-deliver-video-habit-reversal-training-for-bfrbs/2026-07-16T17:30:16+00:00 https://www.psychiatrist.com/jcp/video-therapy-habit-reversal-training-body-focused-repetitive-behaviors/faq/2026-07-16T17:30:16+00:00 https://www.psychiatrist.com/jcp/video-therapy-habit-reversal-training-body-focused-repetitive-behaviors/clinical-summary/2026-07-16T17:30:16+00:00 https://www.psychiatrist.com/jcp/video-therapy-habit-reversal-training-body-focused-repetitive-behaviors/key-takeaways/2026-07-16T17:30:16+00:00 https://www.psychiatrist.com/pcc/daylight-duration-rtms-treatment-resistant-depression/how-to-schedule-rtms-any-time-of-year/2026-07-15T23:44:01+00:00 https://www.psychiatrist.com/pcc/daylight-duration-rtms-treatment-resistant-depression/key-takeaways/2026-07-15T23:44:00+00:00 https://www.psychiatrist.com/pcc/daylight-duration-rtms-treatment-resistant-depression/faq/2026-07-15T23:43:59+00:00 https://www.psychiatrist.com/jcp/latency-lai-antipsychotic-initiation-hospitalization-first-episode-schizophrenia/how-to-counsel-and-monitor-early-lai-treatment-schizophrenia/2026-07-15T23:41:16+00:00 https://www.psychiatrist.com/jcp/latency-lai-antipsychotic-initiation-hospitalization-first-episode-schizophrenia/how-to-time-lai-initiation-in-newly-diagnosed-schizophrenia/2026-07-15T23:41:16+00:00 https://www.psychiatrist.com/jcp/latency-lai-antipsychotic-initiation-hospitalization-first-episode-schizophrenia/faq/2026-07-15T23:41:16+00:00 https://www.psychiatrist.com/jcp/latency-lai-antipsychotic-initiation-hospitalization-first-episode-schizophrenia/clinical-summary/2026-07-15T23:41:16+00:00 https://www.psychiatrist.com/jcp/latency-lai-antipsychotic-initiation-hospitalization-first-episode-schizophrenia/key-takeaways/2026-07-15T23:41:16+00:00 https://www.psychiatrist.com/jcp/intrusive-thoughts-infant-related-sexual-harm-prevalence-assessment-safety/how-to-ask-about-postpartum-sexual-harm-intrusive-thoughts/2026-07-15T23:41:09+00:00 https://www.psychiatrist.com/jcp/intrusive-thoughts-infant-related-sexual-harm-prevalence-assessment-safety/faq/2026-07-15T23:41:09+00:00 https://www.psychiatrist.com/jcp/intrusive-thoughts-infant-related-sexual-harm-prevalence-assessment-safety/clinical-summary/2026-07-15T23:41:09+00:00 https://www.psychiatrist.com/jcp/intrusive-thoughts-infant-related-sexual-harm-prevalence-assessment-safety/key-takeaways/2026-07-15T23:41:09+00:00 https://www.psychiatrist.com/jcp/intrusive-thoughts-infant-related-sexual-harm-prevalence-assessment-safety/how-to-assess-safety-after-postpartum-sexual-harm-intrusive-thoughts/2026-07-15T23:41:08+00:00 https://www.psychiatrist.com/jcp/benzodiazepine-prescribing-adults-united-states-medical-expenditure-panel-survey/clinical-summary/2026-07-09T19:16:19+00:00 https://www.psychiatrist.com/jcp/benzodiazepine-prescribing-adults-united-states-medical-expenditure-panel-survey/key-takeaways/2026-07-09T19:16:19+00:00 https://www.psychiatrist.com/jcp/benzodiazepine-prescribing-adults-united-states-medical-expenditure-panel-survey/how-to-check-benzodiazepine-patients-for-cns-depressant-overlap/2026-07-09T19:16:18+00:00 https://www.psychiatrist.com/jcp/benzodiazepine-prescribing-adults-united-states-medical-expenditure-panel-survey/faq/2026-07-09T19:16:18+00:00 https://www.psychiatrist.com/jcp/postmarketing-transcranial-magnetic-stimulation-maude-database-adverse-events-advancements/clinical-summary/2026-07-09T19:16:09+00:00 https://www.psychiatrist.com/jcp/postmarketing-transcranial-magnetic-stimulation-maude-database-adverse-events-advancements/key-takeaways/2026-07-09T19:16:09+00:00 https://www.psychiatrist.com/jcp/postmarketing-transcranial-magnetic-stimulation-maude-database-adverse-events-advancements/how-to-document-and-report-tms-adverse-events/2026-07-09T19:16:08+00:00 https://www.psychiatrist.com/jcp/postmarketing-transcranial-magnetic-stimulation-maude-database-adverse-events-advancements/how-to-monitor-tms-patients-for-adverse-effects/2026-07-09T19:16:08+00:00 https://www.psychiatrist.com/jcp/postmarketing-transcranial-magnetic-stimulation-maude-database-adverse-events-advancements/faq/2026-07-09T19:16:08+00:00 https://www.psychiatrist.com/pcc/suicidal-mental-imagery-suicide-attempters/how-to-assess-suicidal-mental-imagery-after-attempt/2026-07-09T19:16:00+00:00 https://www.psychiatrist.com/pcc/suicidal-mental-imagery-suicide-attempters/faq/2026-07-09T19:16:00+00:00 https://www.psychiatrist.com/pcc/suicidal-mental-imagery-suicide-attempters/clinical-summary/2026-07-09T19:16:00+00:00 https://www.psychiatrist.com/pcc/suicidal-mental-imagery-suicide-attempters/key-takeaways/2026-07-09T19:16:00+00:00 https://www.psychiatrist.com/jcp/effects-extended-cannabis-abstinence-comorbid-ptsd-cannabis-use-disorder/how-to-verify-cannabis-abstinence-in-ptsd-cud/2026-07-09T19:15:50+00:00 https://www.psychiatrist.com/jcp/effects-extended-cannabis-abstinence-comorbid-ptsd-cannabis-use-disorder/how-to-counsel-cannabis-abstinence-in-ptsd-cud/2026-07-09T19:15:50+00:00 https://www.psychiatrist.com/jcp/effects-extended-cannabis-abstinence-comorbid-ptsd-cannabis-use-disorder/faq/2026-07-09T19:15:50+00:00 https://www.psychiatrist.com/jcp/effects-extended-cannabis-abstinence-comorbid-ptsd-cannabis-use-disorder/clinical-summary/2026-07-09T19:15:50+00:00 https://www.psychiatrist.com/jcp/effects-extended-cannabis-abstinence-comorbid-ptsd-cannabis-use-disorder/key-takeaways/2026-07-09T19:15:50+00:00 https://www.psychiatrist.com/pcc/validation-adapted-scale-perception-respect-maintenance-dignity-inpatient/how-to-assess-inpatient-dignity-with-apremdi-scale/2026-07-09T19:15:43+00:00 https://www.psychiatrist.com/pcc/validation-adapted-scale-perception-respect-maintenance-dignity-inpatient/faq/2026-07-09T19:15:43+00:00 https://www.psychiatrist.com/pcc/validation-adapted-scale-perception-respect-maintenance-dignity-inpatient/clinical-summary/2026-07-09T19:15:43+00:00 https://www.psychiatrist.com/pcc/validation-adapted-scale-perception-respect-maintenance-dignity-inpatient/key-takeaways/2026-07-09T19:15:43+00:00 https://www.psychiatrist.com/jcp/outcomes-practice-patterns-long-acting-injectable-vs-oral-antipsychotics-bipolar-i-us/how-to-review-lai-continuation-after-bipolar-rehospitalization/2026-07-09T19:15:37+00:00 https://www.psychiatrist.com/jcp/outcomes-practice-patterns-long-acting-injectable-vs-oral-antipsychotics-bipolar-i-us/how-to-consider-lai-at-discharge-for-bipolar-i/2026-07-09T19:15:37+00:00 https://www.psychiatrist.com/jcp/outcomes-practice-patterns-long-acting-injectable-vs-oral-antipsychotics-bipolar-i-us/faq/2026-07-09T19:15:37+00:00 https://www.psychiatrist.com/jcp/outcomes-practice-patterns-long-acting-injectable-vs-oral-antipsychotics-bipolar-i-us/clinical-summary/2026-07-09T19:15:37+00:00 https://www.psychiatrist.com/jcp/outcomes-practice-patterns-long-acting-injectable-vs-oral-antipsychotics-bipolar-i-us/key-takeaways/2026-07-09T19:15:37+00:00 https://www.psychiatrist.com/jcp/temporal-dynamics-antidepressant-response-brexanolone-treatment-postpartum-depression/how-to-select-and-monitor-brexanolone-for-postpartum-depression/2026-07-09T18:47:36+00:00 https://www.psychiatrist.com/jcp/temporal-dynamics-antidepressant-response-brexanolone-treatment-postpartum-depression/faq/2026-07-09T18:47:36+00:00 https://www.psychiatrist.com/jcp/temporal-dynamics-antidepressant-response-brexanolone-treatment-postpartum-depression/clinical-summary/2026-07-09T18:47:36+00:00 https://www.psychiatrist.com/jcp/temporal-dynamics-antidepressant-response-brexanolone-treatment-postpartum-depression/key-takeaways/2026-07-09T18:47:36+00:00 https://www.psychiatrist.com/jcp/temporal-dynamics-antidepressant-response-brexanolone-treatment-postpartum-depression/how-to-track-early-recovery-during-brexanolone-treatment/2026-07-09T18:47:35+00:00 https://www.psychiatrist.com/jcp/comparing-risk-prediction-for-suicide-attempts-and-deaths-after-emergency-department-visits-for-individuals-with-mental-health-disorders/how-to-use-nonfatal-suicide-model-for-death-risk/2026-07-09T18:47:11+00:00 https://www.psychiatrist.com/jcp/comparing-risk-prediction-for-suicide-attempts-and-deaths-after-emergency-department-visits-for-individuals-with-mental-health-disorders/how-to-stratify-post-ed-suicide-risk-mental-health/2026-07-09T18:47:11+00:00 https://www.psychiatrist.com/jcp/comparing-risk-prediction-for-suicide-attempts-and-deaths-after-emergency-department-visits-for-individuals-with-mental-health-disorders/faq/2026-07-09T18:47:11+00:00 https://www.psychiatrist.com/jcp/comparing-risk-prediction-for-suicide-attempts-and-deaths-after-emergency-department-visits-for-individuals-with-mental-health-disorders/clinical-summary/2026-07-09T18:47:11+00:00 https://www.psychiatrist.com/jcp/comparing-risk-prediction-for-suicide-attempts-and-deaths-after-emergency-department-visits-for-individuals-with-mental-health-disorders/key-takeaways/2026-07-09T18:47:11+00:00 https://www.psychiatrist.com/jcp/safety-efficacy-maintenance-aripiprazole-once-monthly-black-adults-bipolar-i-disorder/how-to-use-aom-400-maintenance-bipolar-i/2026-07-09T18:46:18+00:00 https://www.psychiatrist.com/jcp/safety-efficacy-maintenance-aripiprazole-once-monthly-black-adults-bipolar-i-disorder/faq/2026-07-09T18:46:18+00:00 https://www.psychiatrist.com/jcp/safety-efficacy-maintenance-aripiprazole-once-monthly-black-adults-bipolar-i-disorder/clinical-summary/2026-07-09T18:46:18+00:00 https://www.psychiatrist.com/jcp/safety-efficacy-maintenance-aripiprazole-once-monthly-black-adults-bipolar-i-disorder/key-takeaways/2026-07-09T18:46:18+00:00 https://www.psychiatrist.com/jcp/neuropsychiatric-symptom-clusters-brain-structure-alzheimers-disease/clinical-summary/2026-07-09T18:46:10+00:00 https://www.psychiatrist.com/jcp/neuropsychiatric-symptom-clusters-brain-structure-alzheimers-disease/key-takeaways/2026-07-09T18:46:10+00:00 https://www.psychiatrist.com/jcp/neuropsychiatric-symptom-clusters-brain-structure-alzheimers-disease/how-to-use-npi-q-clusters-in-alzheimers-disease/2026-07-09T18:46:09+00:00 https://www.psychiatrist.com/jcp/neuropsychiatric-symptom-clusters-brain-structure-alzheimers-disease/faq/2026-07-09T18:46:09+00:00 https://www.psychiatrist.com/jcp/efficacy-olanzapine-samidorphan-negative-symptoms-56-week-patients-schizophrenia/how-to-monitor-negative-symptom-response-to-olanzapine-samidorphan/2026-07-09T18:46:01+00:00 https://www.psychiatrist.com/jcp/efficacy-olanzapine-samidorphan-negative-symptoms-56-week-patients-schizophrenia/how-to-identify-prominent-negative-symptoms-in-schizophrenia/2026-07-09T18:46:01+00:00 https://www.psychiatrist.com/jcp/efficacy-olanzapine-samidorphan-negative-symptoms-56-week-patients-schizophrenia/faq/2026-07-09T18:46:01+00:00 https://www.psychiatrist.com/jcp/efficacy-olanzapine-samidorphan-negative-symptoms-56-week-patients-schizophrenia/clinical-summary/2026-07-09T18:46:01+00:00 https://www.psychiatrist.com/jcp/efficacy-olanzapine-samidorphan-negative-symptoms-56-week-patients-schizophrenia/key-takeaways/2026-07-09T18:46:01+00:00 https://www.psychiatrist.com/pcc/depression-cardiovascular-burden-aging-populations/how-to-prioritize-cardiometabolic-screening-in-depressed-older-adults/2026-07-09T18:45:48+00:00 https://www.psychiatrist.com/pcc/depression-cardiovascular-burden-aging-populations/how-to-use-depressive-symptom-frequency-for-cvd-risk/2026-07-09T18:45:48+00:00 https://www.psychiatrist.com/pcc/depression-cardiovascular-burden-aging-populations/faq/2026-07-09T18:45:48+00:00 https://www.psychiatrist.com/pcc/depression-cardiovascular-burden-aging-populations/clinical-summary/2026-07-09T18:45:48+00:00 https://www.psychiatrist.com/pcc/depression-cardiovascular-burden-aging-populations/key-takeaways/2026-07-09T18:45:48+00:00 https://www.psychiatrist.com/jcp/vagus-nerve-stimulation-suicidal-ideation-treatment-resistant-major-depression-recover/faq/2026-07-08T22:38:10+00:00 https://www.psychiatrist.com/jcp/vagus-nerve-stimulation-suicidal-ideation-treatment-resistant-major-depression-recover/clinical-summary/2026-07-08T22:38:10+00:00 https://www.psychiatrist.com/jcp/vagus-nerve-stimulation-suicidal-ideation-treatment-resistant-major-depression-recover/key-takeaways/2026-07-08T22:38:10+00:00 https://www.psychiatrist.com/jcp/vagus-nerve-stimulation-suicidal-ideation-treatment-resistant-major-depression-recover/how-to-interpret-suicidal-ideation-change-with-vns/2026-07-08T22:38:09+00:00 https://www.psychiatrist.com/jcp/vagus-nerve-stimulation-suicidal-ideation-treatment-resistant-major-depression-recover/how-to-monitor-suicidal-ideation-during-vns-treatment/2026-07-08T22:38:09+00:00 https://www.psychiatrist.com/pcc/meaning-monitoring-patients-families-critical-care-units/how-to-reduce-icu-monitor-related-patient-distress/2026-07-08T22:37:46+00:00 https://www.psychiatrist.com/pcc/meaning-monitoring-patients-families-critical-care-units/how-to-educate-icu-families-about-monitor-alarms/2026-07-08T22:37:46+00:00 https://www.psychiatrist.com/pcc/meaning-monitoring-patients-families-critical-care-units/faq/2026-07-08T22:37:46+00:00 https://www.psychiatrist.com/pcc/meaning-monitoring-patients-families-critical-care-units/clinical-summary/2026-07-08T22:37:46+00:00 https://www.psychiatrist.com/pcc/meaning-monitoring-patients-families-critical-care-units/key-takeaways/2026-07-08T22:37:46+00:00 https://www.psychiatrist.com/jcp/race-ethnicity-socioeconomic-clinical-characteristics-postpartum-depression-history-depressive-episodes/how-to-use-prenatal-phq9-and-medication-course-for-ppd-risk/2026-07-08T22:34:41+00:00 https://www.psychiatrist.com/jcp/race-ethnicity-socioeconomic-clinical-characteristics-postpartum-depression-history-depressive-episodes/how-to-stratify-ppd-risk-in-pregnant-patients-with-depression-history/2026-07-08T22:34:41+00:00 https://www.psychiatrist.com/jcp/race-ethnicity-socioeconomic-clinical-characteristics-postpartum-depression-history-depressive-episodes/faq/2026-07-08T22:34:41+00:00 https://www.psychiatrist.com/jcp/race-ethnicity-socioeconomic-clinical-characteristics-postpartum-depression-history-depressive-episodes/clinical-summary/2026-07-08T22:34:41+00:00 https://www.psychiatrist.com/jcp/race-ethnicity-socioeconomic-clinical-characteristics-postpartum-depression-history-depressive-episodes/key-takeaways/2026-07-08T22:34:41+00:00 https://www.psychiatrist.com/pcc/impulsivity-differential-diagnosis-evaluation-management/clinical-summary/2026-07-08T21:04:16+00:00 https://www.psychiatrist.com/pcc/impulsivity-differential-diagnosis-evaluation-management/how-to-evaluate-new-impulsivity-in-older-adults/2026-07-07T15:54:04+00:00 https://www.psychiatrist.com/pcc/impulsivity-differential-diagnosis-evaluation-management/how-to-manage-frontal-executive-impulsivity-in-older-adults/2026-07-07T15:54:04+00:00 https://www.psychiatrist.com/pcc/impulsivity-differential-diagnosis-evaluation-management/key-takeaways/2026-07-08T17:49:05+00:00 https://www.psychiatrist.com/pcc/impulsivity-differential-diagnosis-evaluation-management/faq/2026-07-08T17:49:01+00:00 https://www.psychiatrist.com/pcc/primary-users-va-health-care-system-prevalence-correlates-implications-care-delivery/how-to-address-mental-health-care-barriers-in-va-veterans/2026-07-07T14:39:27+00:00 https://www.psychiatrist.com/pcc/primary-users-va-health-care-system-prevalence-correlates-implications-care-delivery/how-to-assess-veterans-who-rely-on-va-care/2026-07-07T14:39:27+00:00 https://www.psychiatrist.com/pcc/impact-patients-suicide-mental-health-professionals/how-to-support-clinicians-after-patient-suicide/2026-07-07T14:39:19+00:00 https://www.psychiatrist.com/pcc/impact-patients-suicide-mental-health-professionals/how-to-review-care-after-patient-suicide/2026-07-07T14:39:18+00:00 https://www.psychiatrist.com/jcp/us-mortality-obesity-psychiatric-disorders-trends-disparities-projections/how-to-prioritize-metabolic-care-in-psychiatric-patients/2026-07-07T14:39:12+00:00 https://www.psychiatrist.com/jcp/major-depressive-disorder-ptsd-outcome-interpersonal-psychotherapy-prolonged-exposure/how-to-monitor-ptsd-psychotherapy-outcomes-by-mdd-status/2026-07-07T14:38:57+00:00 https://www.psychiatrist.com/jcp/major-depressive-disorder-ptsd-outcome-interpersonal-psychotherapy-prolonged-exposure/how-to-choose-ptsd-psychotherapy-when-mdd-is-present/2026-07-07T14:38:57+00:00 https://www.psychiatrist.com/jcp/major-depressive-disorder-ptsd-outcome-interpersonal-psychotherapy-prolonged-exposure/faq/2026-07-07T14:38:57+00:00 https://www.psychiatrist.com/jcp/major-depressive-disorder-ptsd-outcome-interpersonal-psychotherapy-prolonged-exposure/clinical-summary/2026-07-07T14:38:57+00:00 https://www.psychiatrist.com/jcp/major-depressive-disorder-ptsd-outcome-interpersonal-psychotherapy-prolonged-exposure/key-takeaways/2026-07-07T14:38:57+00:00 https://www.psychiatrist.com/pcc/tablet-shape-size-color-medication-adherence-psychiatric-outpatients/how-to-choose-acceptable-tablet-formulations-in-psychiatric-outpatients/2026-07-07T14:38:43+00:00 https://www.psychiatrist.com/pcc/tablet-shape-size-color-medication-adherence-psychiatric-outpatients/how-to-assess-medication-adherence-in-psychiatric-outpatients/2026-07-07T14:38:43+00:00 https://www.psychiatrist.com/pcc/tablet-shape-size-color-medication-adherence-psychiatric-outpatients/faq/2026-07-07T14:38:43+00:00 https://www.psychiatrist.com/pcc/tablet-shape-size-color-medication-adherence-psychiatric-outpatients/clinical-summary/2026-07-07T14:38:43+00:00 https://www.psychiatrist.com/pcc/tablet-shape-size-color-medication-adherence-psychiatric-outpatients/key-takeaways/2026-07-07T14:38:43+00:00 https://www.psychiatrist.com/jcp/us-mortality-obesity-psychiatric-disorders-trends-disparities-projections/key-takeaways/2026-07-07T14:31:01+00:00 https://www.psychiatrist.com/jcp/us-mortality-obesity-psychiatric-disorders-trends-disparities-projections/faq/2026-07-07T14:31:00+00:00 https://www.psychiatrist.com/jcp/us-mortality-obesity-psychiatric-disorders-trends-disparities-projections/clinical-summary/2026-07-07T14:30:59+00:00 https://www.psychiatrist.com/pcc/impact-patients-suicide-mental-health-professionals/key-takeaways/2026-07-07T14:25:30+00:00 https://www.psychiatrist.com/pcc/impact-patients-suicide-mental-health-professionals/faq/2026-07-07T14:25:29+00:00 https://www.psychiatrist.com/pcc/impact-patients-suicide-mental-health-professionals/clinical-summary/2026-07-07T14:25:28+00:00 https://www.psychiatrist.com/jcp/randomized-controlled-trial-mindfulness-meditation/key-takeaways/2026-07-07T14:21:36+00:00 https://www.psychiatrist.com/jcp/randomized-controlled-trial-mindfulness-meditation/faq/2026-07-07T14:21:35+00:00 https://www.psychiatrist.com/jcp/randomized-controlled-trial-mindfulness-meditation/clinical-summary/2026-07-07T14:21:30+00:00 https://www.psychiatrist.com/jcp/cognitive-behavioral-therapy-adult-anxiety-disorders/key-takeaways/2026-07-07T14:21:26+00:00 https://www.psychiatrist.com/jcp/cognitive-behavioral-therapy-adult-anxiety-disorders/faq/2026-07-07T14:21:25+00:00 https://www.psychiatrist.com/jcp/cognitive-behavioral-therapy-adult-anxiety-disorders/clinical-summary/2026-07-07T14:21:24+00:00 https://www.psychiatrist.com/jcp/posttrauma-benzodiazepine-use-subsequent-ptsd-after-extreme-traumatic-exposure/how-to-interpret-benzodiazepine-use-after-mass-trauma/2026-07-07T14:20:49+00:00 https://www.psychiatrist.com/jcp/posttrauma-benzodiazepine-use-subsequent-ptsd-after-extreme-traumatic-exposure/how-to-use-benzodiazepine-refills-to-reassess-ptsd-risk/2026-07-07T14:20:48+00:00 https://www.psychiatrist.com/jcp/posttrauma-benzodiazepine-use-subsequent-ptsd-after-extreme-traumatic-exposure/key-takeaways/2026-07-07T14:20:43+00:00 https://www.psychiatrist.com/jcp/posttrauma-benzodiazepine-use-subsequent-ptsd-after-extreme-traumatic-exposure/faq/2026-07-07T14:20:40+00:00 https://www.psychiatrist.com/jcp/posttrauma-benzodiazepine-use-subsequent-ptsd-after-extreme-traumatic-exposure/clinical-summary/2026-07-07T14:20:38+00:00 https://www.psychiatrist.com/jcp/predictive-modeling-suicidal-ideation-veterans-phq-2-versus-complex-machine-learning-approaches/key-takeaways/2026-07-07T14:20:18+00:00 https://www.psychiatrist.com/jcp/predictive-modeling-suicidal-ideation-veterans-phq-2-versus-complex-machine-learning-approaches/faq/2026-07-07T14:20:14+00:00 https://www.psychiatrist.com/jcp/predictive-modeling-suicidal-ideation-veterans-phq-2-versus-complex-machine-learning-approaches/how-to-choose-suicidal-ideation-screening-in-veterans/2026-07-07T14:20:08+00:00 https://www.psychiatrist.com/jcp/predictive-modeling-suicidal-ideation-veterans-phq-2-versus-complex-machine-learning-approaches/clinical-summary/2026-07-07T14:20:07+00:00 https://www.psychiatrist.com/pcc/primary-users-va-health-care-system-prevalence-correlates-implications-care-delivery/key-takeaways/2026-06-24T04:38:21+00:00 https://www.psychiatrist.com/pcc/primary-users-va-health-care-system-prevalence-correlates-implications-care-delivery/faq/2026-06-24T04:38:16+00:00 https://www.psychiatrist.com/pcc/primary-users-va-health-care-system-prevalence-correlates-implications-care-delivery/clinical-summary/2026-06-24T04:38:11+00:00 https://www.psychiatrist.com/jcp/inhaled-mebufotenin-gh001-postpartum-depression-phase-2a-open-label-trial/briefs/2026-06-16T17:48:18+00:00 https://www.psychiatrist.com/jcp/risk-factors-ptsd-trauma-exposed-youth-2-year-longitudinal-study/how-to-stratify-ptsd-risk-in-trauma-exposed-youth/2026-06-15T23:10:20+00:00 https://www.psychiatrist.com/jcp/risk-factors-ptsd-trauma-exposed-youth-2-year-longitudinal-study/faq/2026-06-15T23:10:20+00:00 https://www.psychiatrist.com/jcp/risk-factors-ptsd-trauma-exposed-youth-2-year-longitudinal-study/clinical-summary/2026-06-15T23:10:20+00:00 https://www.psychiatrist.com/jcp/risk-factors-ptsd-trauma-exposed-youth-2-year-longitudinal-study/key-takeaways/2026-06-15T23:10:20+00:00 https://www.psychiatrist.com/jcp/improvements-over-time-valbenazine-elderly-adults-tardive-dyskinesia-post-hoc-analyses-2-long-term-studies/how-to-use-valbenazine-for-elderly-tardive-dyskinesia/2026-06-13T01:05:01+00:00 https://www.psychiatrist.com/jcp/improvements-over-time-valbenazine-elderly-adults-tardive-dyskinesia-post-hoc-analyses-2-long-term-studies/faq/2026-06-13T01:05:01+00:00 https://www.psychiatrist.com/jcp/improvements-over-time-valbenazine-elderly-adults-tardive-dyskinesia-post-hoc-analyses-2-long-term-studies/clinical-summary/2026-06-13T01:05:01+00:00 https://www.psychiatrist.com/jcp/improvements-over-time-valbenazine-elderly-adults-tardive-dyskinesia-post-hoc-analyses-2-long-term-studies/key-takeaways/2026-06-13T01:05:01+00:00 https://www.psychiatrist.com/pcc/understanding-role-doctor-patient-media/clinical-summary/2026-06-12T19:13:30+00:00 https://www.psychiatrist.com/pcc/understanding-role-doctor-patient-media/key-takeaways/2026-06-12T19:13:30+00:00 https://www.psychiatrist.com/pcc/understanding-role-doctor-patient-media/how-to-manage-boundaries-with-physician-patients/2026-06-12T19:13:29+00:00 https://www.psychiatrist.com/pcc/understanding-role-doctor-patient-media/how-to-avoid-curbside-care-for-physician-patients/2026-06-12T19:13:29+00:00 https://www.psychiatrist.com/pcc/understanding-role-doctor-patient-media/faq/2026-06-12T19:13:29+00:00 https://www.psychiatrist.com/jcp/cognitive-behavioral-therapy-esketamine-depression-suicidal-ideation-relapse-prevention-cbt-endure/clinical-pearls/2026-06-11T03:16:01+00:00 https://www.psychiatrist.com/jcp/real-world-implementation-xanomeline-trospium-schizophrenia-consensus-report/clinical-summary/2026-06-11T03:16:00+00:00 https://www.psychiatrist.com/jcp/a-phase-2b-multicenter-study-to-evaluate-basmisanil-as-an-adjunctive-treatment-in-patients-with-cognitive-impairment-associated-with-schizophrenia/clinical-pearls/2026-06-11T03:15:54+00:00 https://www.psychiatrist.com/jcp/suicide-risk-veterans-health-administration-use-suicide-attempt-us-military/clinical-pearls/2026-06-11T03:15:53+00:00 https://www.psychiatrist.com/jcp/aripiprazole-bupropion-augmentation-vs-switching-bupropion-treatment-resistant-depression-risk-benefit/how-to-decide-against-aripiprazole-in-overweight-trd/2026-06-11T03:15:51+00:00 https://www.psychiatrist.com/jcp/aripiprazole-bupropion-augmentation-vs-switching-bupropion-treatment-resistant-depression-risk-benefit/how-to-choose-trd-augmentation-by-age-and-bmi/2026-06-11T03:15:51+00:00 https://www.psychiatrist.com/jcp/aripiprazole-bupropion-augmentation-vs-switching-bupropion-treatment-resistant-depression-risk-benefit/faq/2026-06-11T03:15:51+00:00 https://www.psychiatrist.com/jcp/aripiprazole-bupropion-augmentation-vs-switching-bupropion-treatment-resistant-depression-risk-benefit/key-takeaways/2026-06-11T03:15:51+00:00 https://www.psychiatrist.com/jcp/economic-burden-posttraumatic-stress-disorder-united-states-societal-perspective/how-to-prioritize-ptsd-screening-in-underrecognized-adults/2026-06-11T03:15:40+00:00 https://www.psychiatrist.com/jcp/economic-burden-posttraumatic-stress-disorder-united-states-societal-perspective/faq/2026-06-11T03:15:40+00:00 https://www.psychiatrist.com/jcp/economic-burden-posttraumatic-stress-disorder-united-states-societal-perspective/key-takeaways/2026-06-11T03:15:40+00:00 https://www.psychiatrist.com/jcp/economic-burden-posttraumatic-stress-disorder-united-states-societal-perspective/how-to-assess-functional-and-sud-burden-in-ptsd/2026-06-11T03:15:39+00:00 https://www.psychiatrist.com/pcc/depression-remission-response-rates-anxiety-predictor-depression-response-ect/how-to-monitor-community-ect-response-in-severe-depression/2026-06-11T03:14:38+00:00 https://www.psychiatrist.com/pcc/depression-remission-response-rates-anxiety-predictor-depression-response-ect/faq/2026-06-11T03:14:38+00:00 https://www.psychiatrist.com/pcc/depression-remission-response-rates-anxiety-predictor-depression-response-ect/key-takeaways/2026-06-11T03:14:38+00:00 https://www.psychiatrist.com/pcc/conflict-mediation-cognitive-behavioral-therapy-new-psychotherapeutic-strategy/how-to-use-want-can-must-for-conflict-mediation/2026-06-11T03:14:37+00:00 https://www.psychiatrist.com/pcc/conflict-mediation-cognitive-behavioral-therapy-new-psychotherapeutic-strategy/faq/2026-06-11T03:14:37+00:00 https://www.psychiatrist.com/pcc/conflict-mediation-cognitive-behavioral-therapy-new-psychotherapeutic-strategy/key-takeaways/2026-06-11T03:14:37+00:00 https://www.psychiatrist.com/pcc/depression-remission-response-rates-anxiety-predictor-depression-response-ect/how-to-screen-anxiety-before-ect-for-depression/2026-06-11T03:14:37+00:00 https://www.psychiatrist.com/jcp/fluctuating-adhd-multimodal-treatment-of-adhd-mta-study/how-to-monitor-longitudinal-adhd-course-over-time/2026-06-11T03:14:36+00:00 https://www.psychiatrist.com/jcp/fluctuating-adhd-multimodal-treatment-of-adhd-mta-study/how-to-review-environmental-demands-in-fluctuating-adhd/2026-06-11T03:14:36+00:00 https://www.psychiatrist.com/jcp/fluctuating-adhd-multimodal-treatment-of-adhd-mta-study/how-to-monitor-fluctuating-adhd-over-time/2026-06-11T03:14:36+00:00 https://www.psychiatrist.com/jcp/fluctuating-adhd-multimodal-treatment-of-adhd-mta-study/faq/2026-06-11T03:14:36+00:00 https://www.psychiatrist.com/jcp/fluctuating-adhd-multimodal-treatment-of-adhd-mta-study/clinical-summary/2026-06-11T03:14:36+00:00 https://www.psychiatrist.com/jcp/fluctuating-adhd-multimodal-treatment-of-adhd-mta-study/key-takeaways/2026-06-11T03:14:36+00:00 https://www.psychiatrist.com/jcp/fluctuating-adhd-multimodal-treatment-of-adhd-mta-study/how-to-use-environmental-demands-in-fluctuating-adhd/2026-06-11T03:14:35+00:00 https://www.psychiatrist.com/pcc/side-effect-profiles-selective-serotonin-reuptake-inhibitors-cross-sectional-study-naturalistic-setting/how-to-use-side-effect-patterns-to-choose-ssris/2026-06-11T03:14:35+00:00 https://www.psychiatrist.com/pcc/side-effect-profiles-selective-serotonin-reuptake-inhibitors-cross-sectional-study-naturalistic-setting/how-to-screen-outpatients-on-ssris-for-side-effects/2026-06-11T03:14:35+00:00 https://www.psychiatrist.com/pcc/side-effect-profiles-selective-serotonin-reuptake-inhibitors-cross-sectional-study-naturalistic-setting/how-to-monitor-escitalopram-and-sertraline-side-effects/2026-06-11T03:14:34+00:00 https://www.psychiatrist.com/pcc/side-effect-profiles-selective-serotonin-reuptake-inhibitors-cross-sectional-study-naturalistic-setting/how-to-assess-ssri-side-effects-in-outpatients/2026-06-11T03:14:34+00:00 https://www.psychiatrist.com/pcc/side-effect-profiles-selective-serotonin-reuptake-inhibitors-cross-sectional-study-naturalistic-setting/faq/2026-06-11T03:14:34+00:00 https://www.psychiatrist.com/pcc/side-effect-profiles-selective-serotonin-reuptake-inhibitors-cross-sectional-study-naturalistic-setting/clinical-summary/2026-06-11T03:14:34+00:00 https://www.psychiatrist.com/pcc/side-effect-profiles-selective-serotonin-reuptake-inhibitors-cross-sectional-study-naturalistic-setting/key-takeaways/2026-06-11T03:14:34+00:00 https://www.psychiatrist.com/jcp/prevalence-national-burden-treatment-resistant-depression-major-depressive-disorder-in-us/how-to-identify-treatment-resistant-depression-in-medicated-mdd/2026-06-11T03:14:33+00:00 https://www.psychiatrist.com/jcp/prevalence-national-burden-treatment-resistant-depression-major-depressive-disorder-in-us/how-to-identify-treatment-resistant-depression-in-treated-mdd/2026-06-11T03:14:33+00:00 https://www.psychiatrist.com/jcp/prevalence-national-burden-treatment-resistant-depression-major-depressive-disorder-in-us/faq/2026-06-11T03:14:33+00:00 https://www.psychiatrist.com/jcp/prevalence-national-burden-treatment-resistant-depression-major-depressive-disorder-in-us/clinical-summary/2026-06-11T03:14:33+00:00 https://www.psychiatrist.com/jcp/prevalence-national-burden-treatment-resistant-depression-major-depressive-disorder-in-us/key-takeaways/2026-06-11T03:14:33+00:00 https://www.psychiatrist.com/jcp/validity-online-adhd-assessment-real-world-sample-adults-seeking-web-based-mental-healthcare/how-to-interpret-positive-online-adhd-assessment-adults/2026-06-11T03:14:32+00:00 https://www.psychiatrist.com/jcp/validity-online-adhd-assessment-real-world-sample-adults-seeking-web-based-mental-healthcare/faq/2026-06-11T03:14:32+00:00 https://www.psychiatrist.com/jcp/validity-online-adhd-assessment-real-world-sample-adults-seeking-web-based-mental-healthcare/clinical-summary/2026-06-11T03:14:32+00:00 https://www.psychiatrist.com/jcp/validity-online-adhd-assessment-real-world-sample-adults-seeking-web-based-mental-healthcare/key-takeaways/2026-06-11T03:14:32+00:00 https://www.psychiatrist.com/jcp/lumateperone-adjunctive-therapy-major-depressive-disorder-randomized-double-blind-phase-3-trial/key-takeaways/2026-06-11T03:14:31+00:00 https://www.psychiatrist.com/jcp/validity-online-adhd-assessment-real-world-sample-adults-seeking-web-based-mental-healthcare/how-to-manage-negative-online-adhd-assessment-adults/2026-06-11T03:14:31+00:00 https://www.psychiatrist.com/jcp/lumateperone-adjunctive-therapy-major-depressive-disorder-randomized-double-blind-phase-3-trial/how-to-use-adjunctive-lumateperone-in-mdd/2026-06-11T03:14:30+00:00 https://www.psychiatrist.com/jcp/lumateperone-adjunctive-therapy-major-depressive-disorder-randomized-double-blind-phase-3-trial/faq/2026-06-11T03:14:30+00:00 https://www.psychiatrist.com/jcp/lumateperone-adjunctive-therapy-major-depressive-disorder-randomized-double-blind-phase-3-trial/clinical-summary/2026-06-11T03:14:30+00:00 https://www.psychiatrist.com/pcc/early-improvement-predictor-treatment-response-patients-obsessive-compulsive-disorder-12-week-randomized-trial-sertraline-fluvoxamine/how-to-choose-between-sertraline-and-fluvoxamine-for-ocd/2026-06-11T03:14:29+00:00 https://www.psychiatrist.com/pcc/early-improvement-predictor-treatment-response-patients-obsessive-compulsive-disorder-12-week-randomized-trial-sertraline-fluvoxamine/how-to-use-early-ybocs-change-in-ocd/2026-06-11T03:14:29+00:00 https://www.psychiatrist.com/pcc/early-improvement-predictor-treatment-response-patients-obsessive-compulsive-disorder-12-week-randomized-trial-sertraline-fluvoxamine/faq/2026-06-11T03:14:29+00:00 https://www.psychiatrist.com/pcc/early-improvement-predictor-treatment-response-patients-obsessive-compulsive-disorder-12-week-randomized-trial-sertraline-fluvoxamine/clinical-summary/2026-06-11T03:14:29+00:00 https://www.psychiatrist.com/pcc/early-improvement-predictor-treatment-response-patients-obsessive-compulsive-disorder-12-week-randomized-trial-sertraline-fluvoxamine/key-takeaways/2026-06-11T03:14:29+00:00 https://www.psychiatrist.com/jcp/repeated-ketamine-infusion-vs-intranasal-esketamine-patients-treatment-resistant-depression-chart-review/key-takeaways/2026-06-11T03:14:28+00:00 https://www.psychiatrist.com/jcp/repeated-ketamine-infusion-vs-intranasal-esketamine-patients-treatment-resistant-depression-chart-review/how-to-choose-iv-ketamine-vs-esketamine-trd/2026-06-11T03:14:27+00:00 https://www.psychiatrist.com/jcp/repeated-ketamine-infusion-vs-intranasal-esketamine-patients-treatment-resistant-depression-chart-review/how-to-select-outpatients-for-ketamine-trd-induction/2026-06-11T03:14:27+00:00 https://www.psychiatrist.com/jcp/repeated-ketamine-infusion-vs-intranasal-esketamine-patients-treatment-resistant-depression-chart-review/faq/2026-06-11T03:14:27+00:00 https://www.psychiatrist.com/jcp/repeated-ketamine-infusion-vs-intranasal-esketamine-patients-treatment-resistant-depression-chart-review/clinical-summary/2026-06-11T03:14:27+00:00 https://www.psychiatrist.com/jcp/efficacy-safety-of-axs-05-dextromethorphan-bupropion-mdd/how-to-initiate-dextromethorphan-bupropion-for-acute-mdd/2026-06-11T03:14:26+00:00 https://www.psychiatrist.com/jcp/efficacy-safety-of-axs-05-dextromethorphan-bupropion-mdd/faq/2026-06-11T03:14:26+00:00 https://www.psychiatrist.com/jcp/efficacy-safety-of-axs-05-dextromethorphan-bupropion-mdd/clinical-summary/2026-06-11T03:14:26+00:00 https://www.psychiatrist.com/jcp/efficacy-safety-of-axs-05-dextromethorphan-bupropion-mdd/key-takeaways/2026-06-11T03:14:26+00:00 https://www.psychiatrist.com/pcc/ultra-low-dose-mirtazapine-adult-chronic-insomnia/how-to-monitor-insomnia-response-with-isi-after-mirtazapine/2026-06-11T03:14:02+00:00 https://www.psychiatrist.com/pcc/ultra-low-dose-mirtazapine-adult-chronic-insomnia/how-to-consider-ultra-low-dose-mirtazapine-for-chronic-insomnia/2026-06-11T03:14:02+00:00 https://www.psychiatrist.com/pcc/ultra-low-dose-mirtazapine-adult-chronic-insomnia/faq/2026-06-11T03:14:02+00:00 https://www.psychiatrist.com/pcc/ultra-low-dose-mirtazapine-adult-chronic-insomnia/clinical-summary/2026-06-11T03:14:02+00:00 https://www.psychiatrist.com/pcc/ultra-low-dose-mirtazapine-adult-chronic-insomnia/key-takeaways/2026-06-11T03:14:02+00:00 https://www.psychiatrist.com/jcp/lemborexant-daridorexant-treatment-insomnia-indirect-comparison-using-nnt-nnh-lhh/faq/2026-06-11T03:13:51+00:00 https://www.psychiatrist.com/jcp/lemborexant-daridorexant-treatment-insomnia-indirect-comparison-using-nnt-nnh-lhh/clinical-summary/2026-06-11T03:13:51+00:00 https://www.psychiatrist.com/jcp/lemborexant-daridorexant-treatment-insomnia-indirect-comparison-using-nnt-nnh-lhh/key-takeaways/2026-06-11T03:13:51+00:00 https://www.psychiatrist.com/jcp/lemborexant-daridorexant-treatment-insomnia-indirect-comparison-using-nnt-nnh-lhh/how-to-start-and-escalate-lemborexant-for-adult-insomnia/2026-06-11T03:13:50+00:00 https://www.psychiatrist.com/jcp/lemborexant-daridorexant-treatment-insomnia-indirect-comparison-using-nnt-nnh-lhh/how-to-choose-between-lemborexant-and-daridorexant-for-adult-insomnia/2026-06-11T03:13:50+00:00 https://www.psychiatrist.com/jcp/rapid-onset-sustained-efficacy-onfasprodil-mij821-novel-nr2b-negative-allosteric-modulator-treatment-resistant-depression-phase-2-randomized-proof-of-concept-study/how-to-identify-treatment-resistant-depression-for-onfasprodil-consideration/2026-06-11T03:13:43+00:00 https://www.psychiatrist.com/jcp/rapid-onset-sustained-efficacy-onfasprodil-mij821-novel-nr2b-negative-allosteric-modulator-treatment-resistant-depression-phase-2-randomized-proof-of-concept-study/faq/2026-06-11T03:13:43+00:00 https://www.psychiatrist.com/jcp/rapid-onset-sustained-efficacy-onfasprodil-mij821-novel-nr2b-negative-allosteric-modulator-treatment-resistant-depression-phase-2-randomized-proof-of-concept-study/clinical-summary/2026-06-11T03:13:43+00:00 https://www.psychiatrist.com/jcp/rapid-onset-sustained-efficacy-onfasprodil-mij821-novel-nr2b-negative-allosteric-modulator-treatment-resistant-depression-phase-2-randomized-proof-of-concept-study/key-takeaways/2026-06-11T03:13:43+00:00 https://www.psychiatrist.com/jcp/rapid-onset-sustained-efficacy-onfasprodil-mij821-novel-nr2b-negative-allosteric-modulator-treatment-resistant-depression-phase-2-randomized-proof-of-concept-study/how-to-monitor-response-and-adverse-effects-after-onfasprodil-infusion/2026-06-11T03:13:42+00:00 https://www.psychiatrist.com/pcc/attitudes-emergency-department-nurses-violent-patients/how-to-assess-ed-nurse-attitudes-to-aggression/2026-06-11T03:11:10+00:00 https://www.psychiatrist.com/pcc/attitudes-emergency-department-nurses-violent-patients/faq/2026-06-11T03:11:10+00:00 https://www.psychiatrist.com/pcc/attitudes-emergency-department-nurses-violent-patients/clinical-summary/2026-06-11T03:11:10+00:00 https://www.psychiatrist.com/pcc/attitudes-emergency-department-nurses-violent-patients/key-takeaways/2026-06-11T03:11:10+00:00 https://www.psychiatrist.com/jcp/economic-burden-schizophrenia-united-states/how-to-prioritize-schizophrenia-care-targets-by-cost-drivers/2026-06-10T21:13:24+00:00 https://www.psychiatrist.com/jcp/economic-burden-schizophrenia-united-states/faq/2026-06-10T21:13:24+00:00 https://www.psychiatrist.com/jcp/economic-burden-schizophrenia-united-states/clinical-summary/2026-06-10T21:13:24+00:00 https://www.psychiatrist.com/jcp/economic-burden-schizophrenia-united-states/key-takeaways/2026-06-10T21:13:24+00:00 https://www.psychiatrist.com/pcc/screening-bipolar-i-disorder-rapid-mood-screener-results-nationwide-health-care-provider-survey/how-to-rescreen-patients-with-depression-for-bipolar-i-disorder/2026-06-10T21:13:15+00:00 https://www.psychiatrist.com/pcc/screening-bipolar-i-disorder-rapid-mood-screener-results-nationwide-health-care-provider-survey/how-to-screen-patients-with-depressive-symptoms-for-bipolar-i-disorder/2026-06-10T21:13:15+00:00 https://www.psychiatrist.com/pcc/screening-bipolar-i-disorder-rapid-mood-screener-results-nationwide-health-care-provider-survey/faq/2026-06-10T21:13:15+00:00 https://www.psychiatrist.com/pcc/screening-bipolar-i-disorder-rapid-mood-screener-results-nationwide-health-care-provider-survey/clinical-summary/2026-06-10T21:13:15+00:00 https://www.psychiatrist.com/pcc/screening-bipolar-i-disorder-rapid-mood-screener-results-nationwide-health-care-provider-survey/key-takeaways/2026-06-10T21:13:15+00:00 https://www.psychiatrist.com/jcp/yoga-adjunctive-treatment-posttraumatic-stress-disorder/clinical-summary/2026-06-10T21:13:05+00:00 https://www.psychiatrist.com/jcp/yoga-adjunctive-treatment-posttraumatic-stress-disorder/key-takeaways/2026-06-10T21:13:05+00:00 https://www.psychiatrist.com/jcp/yoga-adjunctive-treatment-posttraumatic-stress-disorder/how-to-refer-women-with-ptsd-to-trauma-informed-yoga/2026-06-10T21:13:04+00:00 https://www.psychiatrist.com/jcp/yoga-adjunctive-treatment-posttraumatic-stress-disorder/faq/2026-06-10T21:13:04+00:00 https://www.psychiatrist.com/jcp/detecting-tardive-dyskinesia-using-video-based-artificial-intelligence/how-to-follow-up-ai-screening-for-suspected-tardive-dyskinesia/2026-06-10T21:12:32+00:00 https://www.psychiatrist.com/jcp/detecting-tardive-dyskinesia-using-video-based-artificial-intelligence/how-to-screen-remotely-for-suspected-tardive-dyskinesia/2026-06-10T21:12:32+00:00 https://www.psychiatrist.com/jcp/detecting-tardive-dyskinesia-using-video-based-artificial-intelligence/faq/2026-06-10T21:12:32+00:00 https://www.psychiatrist.com/jcp/detecting-tardive-dyskinesia-using-video-based-artificial-intelligence/clinical-summary/2026-06-10T21:12:32+00:00 https://www.psychiatrist.com/jcp/detecting-tardive-dyskinesia-using-video-based-artificial-intelligence/key-takeaways/2026-06-10T21:12:32+00:00 https://www.psychiatrist.com/jcp/long-term-outcomes-patients-treatment-refractory-depression-intravenous-ketamine-intranasal-esketamine/how-to-choose-maintenance-iv-ketamine-or-esketamine-for-trd/2026-06-10T21:12:25+00:00 https://www.psychiatrist.com/jcp/long-term-outcomes-patients-treatment-refractory-depression-intravenous-ketamine-intranasal-esketamine/faq/2026-06-10T21:12:25+00:00 https://www.psychiatrist.com/jcp/long-term-outcomes-patients-treatment-refractory-depression-intravenous-ketamine-intranasal-esketamine/clinical-summary/2026-06-10T21:12:25+00:00 https://www.psychiatrist.com/jcp/long-term-outcomes-patients-treatment-refractory-depression-intravenous-ketamine-intranasal-esketamine/key-takeaways/2026-06-10T21:12:25+00:00 https://www.psychiatrist.com/jcp/long-term-outcomes-patients-treatment-refractory-depression-intravenous-ketamine-intranasal-esketamine/how-to-structure-maintenance-ketamine-treatment-for-trd/2026-06-10T21:12:24+00:00 https://www.psychiatrist.com/jcp/correlates-predictors-criminal-legal-involvement-first-episode-psychosis/clinical-summary/2026-06-10T21:12:16+00:00 https://www.psychiatrist.com/jcp/correlates-predictors-criminal-legal-involvement-first-episode-psychosis/key-takeaways/2026-06-10T21:12:16+00:00 https://www.psychiatrist.com/jcp/correlates-predictors-criminal-legal-involvement-first-episode-psychosis/how-to-manage-fep-after-recent-legal-involvement/2026-06-10T21:12:15+00:00 https://www.psychiatrist.com/jcp/correlates-predictors-criminal-legal-involvement-first-episode-psychosis/how-to-assess-cli-risk-in-first-episode-psychosis/2026-06-10T21:12:15+00:00 https://www.psychiatrist.com/jcp/correlates-predictors-criminal-legal-involvement-first-episode-psychosis/faq/2026-06-10T21:12:15+00:00 https://www.psychiatrist.com/pcc/health-belief-model-treatment-adherence-patients-dissociative-disorders/key-takeaways/2026-06-10T21:08:54+00:00 https://www.psychiatrist.com/pcc/health-belief-model-treatment-adherence-patients-dissociative-disorders/how-to-improve-treatment-adherence-in-dissociative-disorders/2026-06-10T21:08:53+00:00 https://www.psychiatrist.com/pcc/health-belief-model-treatment-adherence-patients-dissociative-disorders/how-to-assess-adherence-risk-in-dissociative-disorders/2026-06-10T21:08:53+00:00 https://www.psychiatrist.com/pcc/health-belief-model-treatment-adherence-patients-dissociative-disorders/faq/2026-06-10T21:08:53+00:00 https://www.psychiatrist.com/pcc/health-belief-model-treatment-adherence-patients-dissociative-disorders/clinical-summary/2026-06-10T21:08:53+00:00 https://www.psychiatrist.com/pcc/substance-use-referrals-inpatients-smi-nhhsra/how-to-screen-psychiatric-inpatients-with-smi-for-sud-intervention/2026-06-10T21:07:20+00:00 https://www.psychiatrist.com/pcc/substance-use-referrals-inpatients-smi-nhhsra/faq/2026-06-10T21:07:19+00:00 https://www.psychiatrist.com/pcc/substance-use-referrals-inpatients-smi-nhhsra/key-takeaways/2026-06-10T21:07:18+00:00 https://www.psychiatrist.com/jcp/natural-language-processing-differences-psychotherapeutic-services-ptsd-suicide-risk-veterans/how-to-audit-ptsd-psychotherapy-notes-by-suicide-risk/2026-06-10T21:06:45+00:00 https://www.psychiatrist.com/jcp/natural-language-processing-differences-psychotherapeutic-services-ptsd-suicide-risk-veterans/how-to-stratify-suicide-risk-in-veterans-with-ptsd/2026-06-10T21:06:45+00:00 https://www.psychiatrist.com/jcp/natural-language-processing-differences-psychotherapeutic-services-ptsd-suicide-risk-veterans/faq/2026-06-10T21:06:45+00:00 https://www.psychiatrist.com/jcp/natural-language-processing-differences-psychotherapeutic-services-ptsd-suicide-risk-veterans/clinical-summary/2026-06-10T21:06:45+00:00 https://www.psychiatrist.com/jcp/natural-language-processing-differences-psychotherapeutic-services-ptsd-suicide-risk-veterans/key-takeaways/2026-06-10T21:06:45+00:00 https://www.psychiatrist.com/jcp/hallucinogen-psychosis-associations-are-confounded-baseline-psychiatric-history/how-to-screen-psychiatric-history-before-psychedelic-therapy/2026-06-10T21:06:11+00:00 https://www.psychiatrist.com/jcp/hallucinogen-psychosis-associations-are-confounded-baseline-psychiatric-history/how-to-assess-psychosis-risk-after-hallucinogen-admission/2026-06-10T21:06:11+00:00 https://www.psychiatrist.com/jcp/hallucinogen-psychosis-associations-are-confounded-baseline-psychiatric-history/faq/2026-06-10T21:06:11+00:00 https://www.psychiatrist.com/jcp/hallucinogen-psychosis-associations-are-confounded-baseline-psychiatric-history/clinical-summary/2026-06-10T21:06:11+00:00 https://www.psychiatrist.com/jcp/hallucinogen-psychosis-associations-are-confounded-baseline-psychiatric-history/key-takeaways/2026-06-10T21:06:11+00:00 https://www.psychiatrist.com/pcc/common-methods-suicide-self-inflicted-poisoning-injury-individuals-with-major-depressive-disorder-bipolar-disorder-nationwide-inpatient-sample-analysis/how-to-use-comorbidity-patterns-in-mood-disorder-risk-assessment/2026-06-09T23:20:01+00:00 https://www.psychiatrist.com/pcc/common-methods-suicide-self-inflicted-poisoning-injury-individuals-with-major-depressive-disorder-bipolar-disorder-nationwide-inpatient-sample-analysis/how-to-assess-suicide-method-risk-in-mood-disorders/2026-06-09T23:20:01+00:00 https://www.psychiatrist.com/pcc/common-methods-suicide-self-inflicted-poisoning-injury-individuals-with-major-depressive-disorder-bipolar-disorder-nationwide-inpatient-sample-analysis/how-to-tailor-suicide-means-assessment-in-mood-disorders/2026-06-09T23:20:01+00:00 https://www.psychiatrist.com/pcc/common-methods-suicide-self-inflicted-poisoning-injury-individuals-with-major-depressive-disorder-bipolar-disorder-nationwide-inpatient-sample-analysis/faq/2026-06-09T23:20:01+00:00 https://www.psychiatrist.com/pcc/common-methods-suicide-self-inflicted-poisoning-injury-individuals-with-major-depressive-disorder-bipolar-disorder-nationwide-inpatient-sample-analysis/clinical-summary/2026-06-09T23:20:01+00:00 https://www.psychiatrist.com/pcc/common-methods-suicide-self-inflicted-poisoning-injury-individuals-with-major-depressive-disorder-bipolar-disorder-nationwide-inpatient-sample-analysis/key-takeaways/2026-06-09T23:20:01+00:00 https://www.psychiatrist.com/jcp/county-level-variation-substance-use-disorder-service-utilization-insurance-payers-self-pay/clinical-summary/2026-06-09T20:07:55+00:00 https://www.psychiatrist.com/jcp/county-level-variation-substance-use-disorder-service-utilization-insurance-payers-self-pay/key-takeaways/2026-06-09T20:07:55+00:00 https://www.psychiatrist.com/jcp/county-level-variation-substance-use-disorder-service-utilization-insurance-payers-self-pay/how-to-prioritize-county-sud-access-barriers-by-payer/2026-06-09T20:07:54+00:00 https://www.psychiatrist.com/jcp/county-level-variation-substance-use-disorder-service-utilization-insurance-payers-self-pay/faq/2026-06-09T20:07:54+00:00 https://www.psychiatrist.com/pcc/prevalence-generalized-anxiety-disorder-underserved-venezuelan/how-to-screen-primary-care-adults-for-anxiety-severity/2026-06-09T20:07:43+00:00 https://www.psychiatrist.com/pcc/prevalence-generalized-anxiety-disorder-underserved-venezuelan/faq/2026-06-09T20:07:41+00:00 https://www.psychiatrist.com/pcc/prevalence-generalized-anxiety-disorder-underserved-venezuelan/key-takeaways/2026-06-09T20:07:40+00:00 https://www.psychiatrist.com/pcc/prevalence-generalized-anxiety-disorder-underserved-venezuelan/clinical-summary/2026-06-09T20:07:39+00:00 https://www.psychiatrist.com/jcp/nonsuicidal-self-injury-association-suicidal-ideation-negative-affect/how-to-monitor-nssi-risk-after-suicidal-crisis/2026-06-05T21:10:29+00:00 https://www.psychiatrist.com/jcp/nonsuicidal-self-injury-association-suicidal-ideation-negative-affect/faq/2026-06-05T21:10:28+00:00 https://www.psychiatrist.com/jcp/nonsuicidal-self-injury-association-suicidal-ideation-negative-affect/clinical-summary/2026-06-05T21:10:27+00:00 https://www.psychiatrist.com/pcc/referrals-mental-health-collaborative-care-specialty-mental-health/how-to-triage-cocm-patients-for-specialty-psychiatry/2026-06-05T02:34:58+00:00 https://www.psychiatrist.com/pcc/referrals-mental-health-collaborative-care-specialty-mental-health/faq/2026-06-05T02:34:58+00:00 https://www.psychiatrist.com/pcc/referrals-mental-health-collaborative-care-specialty-mental-health/clinical-summary/2026-06-05T02:34:58+00:00 https://www.psychiatrist.com/pcc/referrals-mental-health-collaborative-care-specialty-mental-health/key-takeaways/2026-06-05T02:34:58+00:00 https://www.psychiatrist.com/pcc/severity-alcohol-craving-euthymic-unipolar-bipolar-patients/how-to-assess-alcohol-craving-in-euthymic-dual-diagnosis/2026-06-05T02:34:45+00:00 https://www.psychiatrist.com/pcc/severity-alcohol-craving-euthymic-unipolar-bipolar-patients/faq/2026-06-05T02:34:45+00:00 https://www.psychiatrist.com/pcc/severity-alcohol-craving-euthymic-unipolar-bipolar-patients/clinical-summary/2026-06-05T02:34:45+00:00 https://www.psychiatrist.com/pcc/severity-alcohol-craving-euthymic-unipolar-bipolar-patients/key-takeaways/2026-06-05T02:34:45+00:00 https://www.psychiatrist.com/pcc/lorazepam-diazepam-alcohol-dependence-syndrome/how-to-use-symptom-triggered-benzodiazepines-alcohol-withdrawal/2026-06-04T22:06:35+00:00 https://www.psychiatrist.com/pcc/lorazepam-diazepam-alcohol-dependence-syndrome/faq/2026-06-04T22:06:35+00:00 https://www.psychiatrist.com/pcc/lorazepam-diazepam-alcohol-dependence-syndrome/clinical-summary/2026-06-04T22:06:35+00:00 https://www.psychiatrist.com/pcc/lorazepam-diazepam-alcohol-dependence-syndrome/key-takeaways/2026-06-04T22:06:35+00:00 https://www.psychiatrist.com/pcc/readability-self-reported-measures-psychosis/how-to-choose-psychosis-self-report-tools-by-readability/2026-06-04T22:06:25+00:00 https://www.psychiatrist.com/pcc/readability-self-reported-measures-psychosis/faq/2026-06-04T22:06:25+00:00 https://www.psychiatrist.com/pcc/readability-self-reported-measures-psychosis/clinical-summary/2026-06-04T22:06:25+00:00 https://www.psychiatrist.com/pcc/readability-self-reported-measures-psychosis/key-takeaways/2026-06-04T22:06:25+00:00 https://www.psychiatrist.com/jcp/nationwide-aftercare-program-for-self-harm-risk-of-self-harm-repetition-suicide/faq/2026-06-04T21:38:04+00:00 https://www.psychiatrist.com/jcp/nationwide-aftercare-program-for-self-harm-risk-of-self-harm-repetition-suicide/how-to-respond-to-repeat-self-harm-during-aftercare/2026-06-04T21:38:02+00:00 https://www.psychiatrist.com/jcp/nationwide-aftercare-program-for-self-harm-risk-of-self-harm-repetition-suicide/how-to-deliver-aftercare-after-hospital-self-harm/2026-06-04T21:38:02+00:00 https://www.psychiatrist.com/pcc/global-research-trends-in-community-psychiatry-a-bibliometric-analysis-2015-2025/faq/2026-06-04T21:35:23+00:00 https://www.psychiatrist.com/pcc/global-research-trends-in-community-psychiatry-a-bibliometric-analysis-2015-2025/clinical-summary/2026-06-04T21:35:23+00:00 https://www.psychiatrist.com/pcc/global-research-trends-in-community-psychiatry-a-bibliometric-analysis-2015-2025/key-takeaways/2026-06-04T21:35:23+00:00 https://www.psychiatrist.com/pcc/global-research-trends-in-community-psychiatry-a-bibliometric-analysis-2015-2025/how-to-search-community-psychiatry-literature-more-completely/2026-06-04T21:35:22+00:00 https://www.psychiatrist.com/pcc/global-research-trends-in-community-psychiatry-a-bibliometric-analysis-2015-2025/how-to-prioritize-community-psychiatry-service-improvement-targets/2026-06-04T21:35:22+00:00 https://www.psychiatrist.com/jcp/suicide-risk-veterans-health-administration-use-suicide-attempt-us-military/faq/2026-06-04T21:27:06+00:00 https://www.psychiatrist.com/jcp/suicide-risk-veterans-health-administration-use-suicide-attempt-us-military/clinical-summary/2026-06-04T21:27:05+00:00 https://www.psychiatrist.com/jcp/suicide-risk-veterans-health-administration-use-suicide-attempt-us-military/key-takeaways/2026-06-04T21:27:05+00:00 https://www.psychiatrist.com/jcp/suicide-risk-veterans-health-administration-use-suicide-attempt-us-military/how-to-prioritize-vha-linkage-after-military-suicide-attempt/2026-06-04T21:27:04+00:00 https://www.psychiatrist.com/jcp/a-phase-2b-multicenter-study-to-evaluate-basmisanil-as-an-adjunctive-treatment-in-patients-with-cognitive-impairment-associated-with-schizophrenia/faq/2026-06-04T21:26:30+00:00 https://www.psychiatrist.com/jcp/a-phase-2b-multicenter-study-to-evaluate-basmisanil-as-an-adjunctive-treatment-in-patients-with-cognitive-impairment-associated-with-schizophrenia/clinical-summary/2026-06-04T21:26:29+00:00 https://www.psychiatrist.com/jcp/a-phase-2b-multicenter-study-to-evaluate-basmisanil-as-an-adjunctive-treatment-in-patients-with-cognitive-impairment-associated-with-schizophrenia/how-to-reduce-practice-effects-in-cias-trials/2026-06-04T21:26:28+00:00 https://www.psychiatrist.com/jcp/a-phase-2b-multicenter-study-to-evaluate-basmisanil-as-an-adjunctive-treatment-in-patients-with-cognitive-impairment-associated-with-schizophrenia/key-takeaways/2026-06-04T21:26:28+00:00 https://www.psychiatrist.com/jcp/cognitive-behavioral-therapy-esketamine-depression-suicidal-ideation-relapse-prevention-cbt-endure/faq/2026-06-04T21:26:16+00:00 https://www.psychiatrist.com/jcp/cognitive-behavioral-therapy-esketamine-depression-suicidal-ideation-relapse-prevention-cbt-endure/clinical-summary/2026-06-04T21:26:15+00:00 https://www.psychiatrist.com/jcp/cognitive-behavioral-therapy-esketamine-depression-suicidal-ideation-relapse-prevention-cbt-endure/key-takeaways/2026-06-04T21:26:15+00:00 https://www.psychiatrist.com/jcp/cognitive-behavioral-therapy-esketamine-depression-suicidal-ideation-relapse-prevention-cbt-endure/how-to-monitor-suicidal-ideation-after-esketamine-and-cbt/2026-06-04T21:26:14+00:00 https://www.psychiatrist.com/jcp/cognitive-behavioral-therapy-esketamine-depression-suicidal-ideation-relapse-prevention-cbt-endure/how-to-add-cbt-after-esketamine-for-mddsi/2026-06-04T21:26:14+00:00 https://www.psychiatrist.com/jcp/intermittent-theta-burst-stimulation-negative-symptoms-schizophrenia-sham-controlled-study/how-to-select-patients-for-itbs-negative-symptoms-schizophrenia/2026-06-04T21:25:22+00:00 https://www.psychiatrist.com/jcp/intermittent-theta-burst-stimulation-negative-symptoms-schizophrenia-sham-controlled-study/how-to-administer-and-monitor-left-dlpfc-itbs-schizophrenia/2026-06-04T21:25:21+00:00 https://www.psychiatrist.com/jcp/intermittent-theta-burst-stimulation-negative-symptoms-schizophrenia-sham-controlled-study/faq/2026-06-04T21:25:20+00:00 https://www.psychiatrist.com/jcp/intermittent-theta-burst-stimulation-negative-symptoms-schizophrenia-sham-controlled-study/clinical-summary/2026-06-04T21:25:18+00:00 https://www.psychiatrist.com/jcp/intermittent-theta-burst-stimulation-negative-symptoms-schizophrenia-sham-controlled-study/key-takeaways/2026-06-04T21:25:17+00:00 https://www.psychiatrist.com/jcp/efficacy-safety-single-dose-psilocybin-chronic-suicidal-ideation-open-label-trial/how-to-monitor-psilocybin-treatment-for-chronic-suicidal-ideation/2026-06-04T20:45:07+00:00 https://www.psychiatrist.com/jcp/efficacy-safety-single-dose-psilocybin-chronic-suicidal-ideation-open-label-trial/how-to-select-patients-for-psilocybin-in-chronic-suicidal-ideation/2026-06-04T20:45:07+00:00 https://www.psychiatrist.com/jcp/efficacy-safety-single-dose-psilocybin-chronic-suicidal-ideation-open-label-trial/faq/2026-06-04T20:45:06+00:00 https://www.psychiatrist.com/jcp/efficacy-safety-single-dose-psilocybin-chronic-suicidal-ideation-open-label-trial/clinical-summary/2026-06-04T20:45:04+00:00 https://www.psychiatrist.com/jcp/efficacy-safety-single-dose-psilocybin-chronic-suicidal-ideation-open-label-trial/key-takeaways/2026-06-04T20:45:03+00:00 https://www.psychiatrist.com/jcp/aripiprazole-once-monthly-schizophrenia-nnt-nnh-lhh/how-to-discuss-aom-400-maintenance-schizophrenia-relapse-prevention/2026-06-04T20:44:49+00:00 https://www.psychiatrist.com/jcp/aripiprazole-once-monthly-schizophrenia-nnt-nnh-lhh/how-to-discuss-aom-400-acute-schizophrenia-benefit-risk/2026-06-04T20:44:49+00:00 https://www.psychiatrist.com/jcp/aripiprazole-once-monthly-schizophrenia-nnt-nnh-lhh/how-to-patient-talk-to-doctor-about-monthly-aripiprazole-shot-for-schizophrenia/2026-06-04T20:44:48+00:00 https://www.psychiatrist.com/jcp/aripiprazole-once-monthly-schizophrenia-nnt-nnh-lhh/faq/2026-06-04T20:44:47+00:00 https://www.psychiatrist.com/jcp/aripiprazole-once-monthly-schizophrenia-nnt-nnh-lhh/clinical-summary/2026-06-04T20:44:45+00:00 https://www.psychiatrist.com/jcp/aripiprazole-once-monthly-schizophrenia-nnt-nnh-lhh/key-takeaways/2026-06-04T20:44:44+00:00 https://www.psychiatrist.com/jcp/differential-impact-cholecystokinin-ghrelin-2-year-avoidant-restrictive-food-intake-disorder/how-to-patient-track-arfid-symptoms-to-discuss-with-your-doctor/2026-06-04T20:44:32+00:00 https://www.psychiatrist.com/jcp/differential-impact-cholecystokinin-ghrelin-2-year-avoidant-restrictive-food-intake-disorder/how-to-consider-fasting-appetite-hormones-in-arfid/2026-06-04T20:44:32+00:00 https://www.psychiatrist.com/jcp/differential-impact-cholecystokinin-ghrelin-2-year-avoidant-restrictive-food-intake-disorder/faq/2026-06-04T20:44:29+00:00 https://www.psychiatrist.com/jcp/differential-impact-cholecystokinin-ghrelin-2-year-avoidant-restrictive-food-intake-disorder/clinical-summary/2026-06-04T20:44:28+00:00 https://www.psychiatrist.com/jcp/differential-impact-cholecystokinin-ghrelin-2-year-avoidant-restrictive-food-intake-disorder/key-takeaways/2026-06-04T20:44:27+00:00 https://www.psychiatrist.com/jcp/inhaled-mebufotenin-gh001-postpartum-depression-phase-2a-open-label-trial/clinical-summary/2026-06-23T20:31:35+00:00 https://www.psychiatrist.com/jcp/real-world-implementation-xanomeline-trospium-schizophrenia-consensus-report/clinical-pearls/2026-06-04T02:23:27+00:00 https://www.psychiatrist.com/jcp/real-world-implementation-xanomeline-trospium-schizophrenia-consensus-report/how-to-cross-titrate-to-xanomeline-trospium-schizophrenia/2026-06-04T01:42:00+00:00 https://www.psychiatrist.com/jcp/real-world-implementation-xanomeline-trospium-schizophrenia-consensus-report/how-to-initiate-xanomeline-trospium-inpatient-schizophrenia-care/2026-06-04T01:42:00+00:00 https://www.psychiatrist.com/jcp/real-world-implementation-xanomeline-trospium-schizophrenia-consensus-report/key-takeaways/2026-06-04T01:41:56+00:00 https://www.psychiatrist.com/jcp/real-world-implementation-xanomeline-trospium-schizophrenia-consensus-report/how-to-start-xanomeline-trospium-outpatients-with-schizophrenia/2026-06-04T01:41:53+00:00 https://www.psychiatrist.com/jcp/real-world-implementation-xanomeline-trospium-schizophrenia-consensus-report/faq/2026-06-04T00:14:30+00:00 https://www.psychiatrist.com/jcp/nationwide-aftercare-program-for-self-harm-risk-of-self-harm-repetition-suicide/clinical-summary/2026-06-02T23:05:41+00:00 https://www.psychiatrist.com/jcp/nationwide-aftercare-program-for-self-harm-risk-of-self-harm-repetition-suicide/key-takeaways/2026-06-02T23:05:40+00:00 https://www.psychiatrist.com/jcp/national-trends-ptsd-us-veterans-2025-2026-national-health-resilience-veterans-study/how-to-patient-talk-to-your-doctor-about-trauma-and-ptsd-as-a-veteran/2026-06-02T23:05:28+00:00 https://www.psychiatrist.com/jcp/national-trends-ptsd-us-veterans-2025-2026-national-health-resilience-veterans-study/how-to-patient-track-how-trauma-affects-your-daily-life/2026-06-02T23:05:27+00:00 https://www.psychiatrist.com/jcp/national-trends-ptsd-us-veterans-2025-2026-national-health-resilience-veterans-study/how-to-assess-functional-burden-of-trauma-in-veterans/2026-06-02T23:05:27+00:00 https://www.psychiatrist.com/jcp/national-trends-ptsd-us-veterans-2025-2026-national-health-resilience-veterans-study/how-to-screen-veterans-for-ptsd-risk/2026-06-02T23:05:26+00:00 https://www.psychiatrist.com/jcp/national-trends-ptsd-us-veterans-2025-2026-national-health-resilience-veterans-study/faq/2026-06-02T23:05:24+00:00 https://www.psychiatrist.com/jcp/national-trends-ptsd-us-veterans-2025-2026-national-health-resilience-veterans-study/clinical-summary/2026-06-02T23:05:21+00:00 https://www.psychiatrist.com/jcp/national-trends-ptsd-us-veterans-2025-2026-national-health-resilience-veterans-study/key-takeaways/2026-06-02T23:05:20+00:00 https://www.psychiatrist.com/jcp/viloxazine-extended-release-adhd-depression-anxiety-open-label-phase-4-trial/how-to-monitor-viloxazine-er-safety-in-adults-with-adhd-comorbid-mood-anxiety/2026-06-02T22:37:23+00:00 https://www.psychiatrist.com/jcp/viloxazine-extended-release-adhd-depression-anxiety-open-label-phase-4-trial/how-to-start-viloxazine-er-in-adults-with-adhd-comorbid-mood-anxiety/2026-06-02T22:29:31+00:00 https://www.psychiatrist.com/jcp/viloxazine-extended-release-adhd-depression-anxiety-open-label-phase-4-trial/faq/2026-06-02T14:52:42+00:00 https://www.psychiatrist.com/jcp/viloxazine-extended-release-adhd-depression-anxiety-open-label-phase-4-trial/clinical-summary/2026-06-02T14:52:41+00:00 https://www.psychiatrist.com/jcp/viloxazine-extended-release-adhd-depression-anxiety-open-label-phase-4-trial/key-takeaways/2026-06-02T14:52:40+00:00 https://www.psychiatrist.com/pcc/readability-english-language-self-report-measures-bipolar-disorder/clinical-summary/2025-11-05T19:30:34+00:00 https://www.psychiatrist.com/pcc/conflict-mediation-cognitive-behavioral-therapy-new-psychotherapeutic-strategy/clinical-summary/2026-06-11T03:14:37+00:00 https://www.psychiatrist.com/jcp/aripiprazole-bupropion-augmentation-vs-switching-bupropion-treatment-resistant-depression-risk-benefit/clinical-summary/2026-06-11T03:15:51+00:00 https://www.psychiatrist.com/jcp/prenatal-exposure-to-second-generation-antipsychotics-and-development-behavior-preschool-aged-children/clinical-summary/2025-10-29T09:43:21+00:00 https://www.psychiatrist.com/pcc/depression-remission-response-rates-anxiety-predictor-depression-response-ect/clinical-summary/2026-06-11T03:14:38+00:00